Osteopathies and chondropathies

M13_OSTEOCHONDRO

secondary hypertrophic osteoarthropathy: Symmetrical osteitis of the four limbs, chiefly localized to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by dorsal kyphosis and joint involvement. It is often secondary to chronic conditions of the lungs and heart. (Dorland, 27th ed)

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M80-M94, M90.6C40.99, M90.6C41.99 Cause of death: ICD-10 — M80-M94, M90.6C40.99, M90.6C41.99 2 out of 7 registries used, show all original rules.	27278
4. Check minimum number of events None	27278
5. Include endpoints M13_OSTEOPOROSIS M13_OSTEOMALACIA M13_BONECONTINUITY M13_BONEDENSOTH M13_OSTEOMYELITIS M13_OSTEONECROSIS M13_PAGET M13_OTHERBONE	30115
6. Filter based on genotype QC (FinnGen only)	29174

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	M13_OSTEOCHONDRO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_OSTEOPOROSIS\|M13_OSTEOMALACIA\|M13_BONECONTINUITY\|M13_BONEDENSOTH\|M13_OSTEOMYELITIS\|M13_OSTEONECROSIS\|M13_PAGET\|M13_OTHERBONE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M8\|M9[0-4]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M8\|M9[0-4]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Osteopathies and chondropathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	238920	147048	90558
Only index persons	211296	130432	80864
Unadjusted period prevalence (%)
Whole population	3.56	4.21	2.53
Only index persons	4.14	4.79	3.09
Median age at first event (years)
Whole population	58.16	67.68	42.65
Only index persons	55.99	65.83	40.12

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	29174	18841	10333
Unadjusted period prevalence (%)	5.99	6.68	4.73
Median age at first event (years)	58.48	60.62	54.58

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
30115: Matched controls
280432

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

4.6

321.7

807

1685

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

320.7

2993

13323

M84.8

ICD-10 Finland

Other disorders of continuity of bone

59.3

320.7

190

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

320.4

3758

18266

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

7.2

319.9

491

642

R4110

NOMESCO Finland

Physiotherapy

1.7

318.8

8208

50914

L76

ICPC

Fracture: other

3.5

318.8

1186

3292

NCK30

NOMESCO Finland

Angulation, rotation or displacement osteotomy of elbow or forearm, other location

20.2

317.2

254

118

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.7

313.7

1765

6225

R06.0

ICD-10 Finland

Dyspnoea

1.7

311.4

7922

48928

G56.4

ICD-10 Finland

Causalgia

13.0

309.8

310

225

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.7

308.0

1796

6450

M89.9

ICD-10 Finland

Disorder of bone, unspecified

72.1

307.9

177

ZXA05

NOMESCO Finland

Left side

1.9

307.7

7834

44725

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

31.8

307.7

1651

511

L95

ICPC

Osteoporosis

8.4

307.7

2728

3299

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

15.6

307.7

2682

1743

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.3

307.7

6346

20942

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

307.7

9478

53649

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

307.7

7494

43151

Z3226

NOMESCO Finland

Physiotherapist

1.9

307.7

5631

30839

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

307.7

4530

20411

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.5

307.7

1842

3304

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

13289

83671

M92.5

ICD-10 Finland

Juvenile osteochondrosis of tibia and fibula

54.4

307.7

318

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

307.7

3568

15950

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.8

307.7

2605

9187

M86.8

ICD-10 Finland

Other osteomyelitis

274.7

307.7

321

M25.5

ICD-10 Finland

Pain in joint

1.8

307.7

9877

59685

J01FF01

ATC

clindamycin; systemic

2.0

307.7

8957

48912

M81.8

ICD-10 Finland

Other osteoporosis

21.8

307.7

888

390

X58

ICD-10 Finland

Exposure to other specified factors

2.2

307.7

4818

21974

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

367.1

307.7

504

A46

ICD-10 Finland

Erysipelas

2.1

307.7

4696

22884

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

334.7

307.7

1041

A06AD11

ATC

lactulose; oral

2.0

307.7

4654

23417

ZXA00

NOMESCO Finland

Right side

1.9

307.7

8418

48330

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

6.9

307.7

1509

2132

NHQ40

NOMESCO Finland

Amputation of toe

9.1

307.7

1060

1117

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

307.7

14047

89542

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.2

307.7

3772

12052

N02AA05

ATC

oxycodone; systemic

2.7

307.7

6860

27645

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.5

307.7

11888

57922

S18

ICPC

Laceration/cut

1.7

307.7

13664

92143

M05BX04

ATC

denosumab; parenteral

8.2

307.7

4607

6012

M85.8

ICD-10 Finland

Other specified disorders of bone density and structure

50.2

307.7

383

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.1

307.7

3009

9578

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

11400

68601

72398

ICD-8 Finland

Other diseases of bone, Alii definiti

+∞

307.7

352

SPAT1216

SPAT

Assessment of functional ability

1.9

307.7

4884

25393

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

307.7

7139

31315

WX212

NOMESCO Finland

Femoral plexus blockade

4.1

307.7

962

2241

L01BA01

ATC

methotrexate; systemic

3.3

307.7

1455

4309

NF3AA

NOMESCO Finland

Femur X-ray examination

4.8

307.7

968

1936

M92.6

ICD-10 Finland

Juvenile osteochondrosis of tarsus

172.0

307.7

220

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

307.7

3273

14155

M81.9

ICD-10 Finland

Osteoporosis, unspecified

26.7

307.7

5527

2344

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

307.7

3390

14587

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.7

307.7

1878

3893

N03AX16

ATC

[U] pregabalin

2.4

307.7

8678

41013

SPAT1254

SPAT

Administration of medicine

2.0

307.7

4837

24688

M05BA06

ATC

ibandronic acid; systemic

6.5

307.7

1136

1669

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

48.1

307.7

2776

591

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

5.5

307.7

982

1693

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

307.7

5426

26743

M94.2

ICD-10 Finland

Chondromalacia

152.3

307.7

1088

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.8

307.7

1248

2487

M05BA04

ATC

alendronic acid; oral

6.6

307.7

6215

10694

N06AX21

ATC

duloxetine; oral

2.2

307.7

3950

18062

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

5.5

307.7

1683

3010

M86.1

ICD-10 Finland

Other acute osteomyelitis

583.1

307.7

372

WX320

NOMESCO Finland

Spinalanesthesy

1.9

307.7

7570

42509

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

307.7

6238

27036

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

307.7

4377

19231

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.8

307.7

1902

6527

318

Kela drug reimbursment

Teriparatide

147.0

307.7

649

S72.0

ICD-10 Finland

Fracture of neck of femur

3.1

307.7

1448

4439

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

170.1

307.7

361

L04AX03

ATC

methotrexate; systemic

2.3

307.7

3252

14195

H05AA02

ATC

teriparatide; parenteral

153.3

307.7

613

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

187.9

307.7

613

72221

ICD-8 Finland

Osteochondrosis, Dissecans

+∞

307.7

488

W19

ICD-10 Finland

Unspecified fall

2.2

307.7

3293

14792

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

307.7

7091

37651

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.8

307.7

1938

6788

M89.0

ICD-10 Finland

Algoneurodystrophy

139.9

307.7

1322

H02AB06

ATC

prednisolone; systemic

1.8

307.7

14949

97560

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

307.7

4782

24591

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.6

307.7

2474

9312

S97

ICPC

Chronic ulcer skin

3.3

307.7

2434

7377

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

307.7

13247

83187

NF1AA

NOMESCO Finland

Hip X-ray examination

3.0

307.7

3648

12354

J01MA12

ATC

levofloxacin; systemic

1.9

307.7

5661

30373

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

292.5

307.7

1264

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

307.7

3939

16941

WX213

NOMESCO Finland

Lower leg blockade

7.9

307.7

478

568

M93.2

ICD-10 Finland

Osteochondritis dissecans

971.0

307.7

911

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.3

307.7

1199

2694

P01BA02

ATC

hydroxychloroquine; oral

2.3

307.7

2804

11900

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

307.7

4333

21225

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

8656

53416

J01DB01

ATC

cefalexin; oral

1.8

307.7

24512

198291

7327A

ICD-9 Finland

Osteochondropathies, Osteochondritis dissecans[OSTEOCHONDRITIS DISSECANS GENUS]

+∞

307.7

341

N03AX12

ATC

[U] gabapentin; oral

2.5

307.7

6160

26340

C03CA01

ATC

furosemide; systemic

2.0

307.7

9862

54207

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.9

307.7

1412

1980

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

530.6

307.7

1256

M85.4

ICD-10 Finland

Solitary bone cyst

166.1

307.7

195

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.4

307.7

950

2076

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

307.7

3629

16209

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

89.8

307.7

605

M84.2

ICD-10 Finland

Delayed union of fracture

168.2

307.7

233

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

20764

152439

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

8.6

307.7

1695

1939

M80

ICD-10 Finland

Osteoporosis with pathological fracture

13.1

307.7

627

453

B01AB05

ATC

enoxaparin; parenteral

1.9

307.7

10242

59164

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

7.1

307.7

511

684

M81.5

ICD-10 Finland

Idiopathic osteoporosis

15.9

307.7

710

425

M05BA07

ATC

risedronic acid; oral

6.9

307.7

2101

3010

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.6

307.7

2405

9117

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

14649

91682

J01MA02

ATC

ciprofloxacin; systemic

1.6

307.7

11417

76049

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

58.9

307.7

510

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

182.8

307.7

784

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.2

307.7

14613

63663

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

307.7

4977

26359

L28

ICPC

Limited function/disability (L)

2.3

307.7

6392

29149

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.6

307.7

1055

2198

L17

ICPC

Foot/toe symptom/complaint

1.7

307.7

8709

53866

SPAT1229

SPAT

Assessment of need for aid

2.7

307.7

2917

10734

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

8321

49193

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.0

307.7

2326

5791

ZXD05

NOMESCO Finland

Urgent procedure

1.8

307.7

9270

54839

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

11.2

307.7

373

313

N02AX02

ATC

tramadol; systemic, rectal

2.3

307.7

14998

85308

M84.0

ICD-10 Finland

Malunion of fracture

298.8

307.7

933

M81.4

ICD-10 Finland

Drug-induced osteoporosis

64.0

307.7

507

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

307.7

2566

9652

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

307.7

12464

83286

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.9

307.7

3675

7698

A28

ICPC

Limited function/disability NOS

2.1

307.7

5638

27170

M05BX03

ATC

strontium ranelate; oral

11.3

307.7

415

347

M86.6

ICD-10 Finland

Other chronic osteomyelitis

849.1

307.7

538

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

82.5

307.7

2726

338

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.6

307.7

4558

13279

S52.5

ICD-10 Finland

Fracture of lower end of radius

2.1

307.7

3420

15917

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

307.7

3819

17722

N02BE01

ATC

paracetamol; systemic, rectal

2.6

307.7

27203

219448

L03

ICPC

Low back symptom/complaint

1.7

307.0

8154

50901

ZX120

NOMESCO Finland

Intravenous

2.2

305.8

3003

13631

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

304.5

10706

71655

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.2

304.3

653

1194

M48.0

ICD-10 Finland

Spinal stenosis

2.0

299.3

3831

19179

R60.0

ICD-10 Finland

Localized oedema

2.0

293.9

3828

19272

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

291.4

2335

9734

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.1

289.4

826

1906

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.0

288.9

1327

4185

S72.1

ICD-10 Finland

Pertrochanteric fracture

4.0

287.5

863

2067

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

287.2

10336

69315

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

286.9

6721

40459

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

285.4

4785

26145

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

282.5

10499

70869

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

282.2

2591

11430

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.4

282.2

2149

8756

L04AX01

ATC

azathioprine; systemic

2.8

281.3

1494

5106

M93.9

ICD-10 Finland

Osteochondropathy, unspecified

82.2

279.7

158

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

277.9

2313

9793

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.6

276.0

1689

6207

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.0

276.0

3456

17136

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

274.6

4001

20883

R50.9

ICD-10 Finland

Fever, unspecified

1.9

274.0

4428

23892

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

273.8

2194

9137

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

273.3

7521

47126

5BA08, ,

NOMESCO Finland

10.6

273.1

311

277

WX002

NOMESCO Finland

Sedation and analgesia

1.7

272.5

5699

33186

NH1AD

NOMESCO Finland

Ankle and foot CT

3.7

271.9

887

2253

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

270.4

1879

7339

9102

FHL

Trepanation or removal of the local bone process

8.0

270.0

380

449

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.8

269.6

1426

4861

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

268.5

2011

8128

A01

ICPC

Pain general/multiple sites

2.1

267.0

2914

13739

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

266.2

5317

30539

N02BF01

ATC

gabapentin; oral

2.2

265.6

2569

11561

N06AX11

ATC

mirtazapine; oral

1.6

263.6

9826

66111

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.1

263.4

1134

3441

N05CF01

ATC

zopiclone; oral

1.6

254.6

9344

62526

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.7

251.8

821

2084

N06AA09

ATC

amitriptyline; systemic

2.0

251.1

2997

14583

UJF32

NOMESCO Finland

Coloscopy

1.6

250.8

7549

48187

H02AB07

ATC

prednisone; oral

1.8

250.2

4103

22187

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

4.5

249.1

640

1361

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.2

248.8

696

1581

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

248.3

8819

58501

A02BC05

ATC

esomeprazole; systemic

1.5

245.2

11655

82359

M94.9

ICD-10 Finland

Disorder of cartilage, unspecified

26.0

244.9

178

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

243.4

3945

21241

Z3231

NOMESCO Finland

Registered nurse

1.6

242.8

7812

50596

SPAT1153

SPAT

Removal of sutures

1.6

241.7

8869

59191

R53

ICD-10 Finland

Malaise and fatigue

1.6

239.7

6917

43623

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

4.8

238.4

559

1103

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

237.8

5130

30001

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

237.3

3649

19315

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.8

236.7

768

1942

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.9

236.0

1207

4036

A02BC01

ATC

omeprazole; systemic

1.6

235.1

7816

50936

M86.4

ICD-10 Finland

Chronic osteomyelitis with draining sinus

+∞

234.4

231

N02BF02

ATC

pregabalin; oral

2.3

233.4

1856

7689

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

231.9

4022

22081

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

231.8

4630

26484

L04AA06

ATC

mycophenolic acid; systemic

3.8

231.7

728

1800

SPAT1301

SPAT

No procedures

1.5

229.4

8952

60416

S22.3

ICD-10 Finland

Fracture of rib

2.2

228.9

2105

9265

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

228.5

5432

32566

L13

ICPC

Hip symptom/complaint

1.7

227.8

5296

31560

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

227.3

3080

15630

L88

ICPC

Rheumatoid/seropositive arthritis

2.6

227.0

1364

4959

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

225.6

1377

5045

SPAT1263

SPAT

Sampling

1.5

224.6

11855

85132

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.0

224.3

1070

3442

M16.7

ICD-10 Finland

Other secondary coxarthrosis

6.3

223.9

387

575

H02AB04

ATC

methylprednisolone; systemic

1.8

223.5

4250

23952

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.0

223.3

1029

3246

R52.2

ICD-10 Finland

Other chronic pain

2.7

221.6

1222

4252

A02BC03

ATC

lansoprazole; oral

1.5

220.8

8119

53987

M93.8

ICD-10 Finland

Other specified osteochondropathies

102.8

219.6

121

R51.80

ICD-10 Finland

Headache

1.7

219.4

4386

25060

H02AB09

ATC

hydrocortisone; systemic

3.3

219.0

847

2405

SPAT1255

SPAT

Intravenous administration of medicine

2.2

218.2

2044

9058

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

3.6

218.0

766

2044

L04AA13

ATC

[U] leflunomide

3.2

217.1

923

2777

M85.9

ICD-10 Finland

Disorder of bone density and structure, unspecified

33.9

216.4

145

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.8

215.9

692

1735

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.4

214.9

1550

6144

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

214.9

11480

82420

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

214.9

3813

21041

E21.0

ICD-10 Finland

Primary hyperparathyroidism

3.8

214.8

677

1677

127

Kela drug reimbursment

Transplant complication

4.1

214.8

605

1381

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.3

214.4

1668

6838

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.6

213.5

1275

4619

R4120

NOMESCO Finland

Occupational therapy

2.2

213.0

1975

8713

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.7

211.0

1177

4118

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

4.0

210.8

626

1486

M01AH05

ATC

etoricoxib; oral

1.5

210.8

17200

133783

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.9

209.4

2973

15300

S72.3

ICD-10 Finland

Fracture of shaft of femur

5.5

208.9

419

720

M85.6

ICD-10 Finland

Other cyst of bone

78.8

207.6

118

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.5

207.4

753

2053

M05BA01

ATC

etidronic acid; systemic

7.8

207.3

298

361

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

207.3

6109

38521

E0000UV, ,

ATC

1.5

206.6

11678

84574

ZZA00

NOMESCO Finland

Split skin graft

3.0

205.7

937

2935

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

204.4

2105

9671

C07AB07

ATC

bisoprolol; oral

1.5

203.0

13342

99336

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

202.5

2166

10093

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

201.7

7841

52576

M02AA07

ATC

piroxicam; topical

1.5

201.2

10076

71160

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

6.5

201.0

338

488

A07EC01

ATC

sulfasalazine; oral, rectal

2.0

200.7

2343

11270

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.6

199.9

687

1806

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.2

199.0

1902

8486

R4180

NOMESCO Finland

Podiatric therapy

4.7

199.0

473

944

L04AA01

ATC

[U] ciclosporin

4.2

198.7

552

1247

M89.3

ICD-10 Finland

Hypertrophy of bone

55.6

198.4

119

M01AH01

ATC

celecoxib; oral

1.6

197.7

5131

31323

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.8

196.5

1063

3659

R03AC02

ATC

salbutamol; inhalant

1.4

194.4

15311

117499

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

193.9

3201

17250

NH3CG

NOMESCO Finland

Extensive MRI of foot

7.2

192.8

296

387

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.3

192.1

742

2104

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.7

191.7

1074

3764

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

190.7

2141

10147

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

190.6

1784

7890

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

8.5

189.8

252

277

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

189.2

14416

109753

Z2446

NOMESCO Finland

Social worker

2.1

188.7

1906

8683

M87.3

ICD-10 Finland

Other secondary osteonecrosis

1678.3

188.5

188

R52.9

ICD-10 Finland

Pain, unspecified

1.9

186.8

2853

15001

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.1

186.0

334

516

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

185.9

1387

5575

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

185.7

5058

31194

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

5.2

185.3

394

714

R03BB04

ATC

tiotropium bromide; inhalant

1.9

185.2

2750

14329

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.2

185.1

772

2295

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

184.3

1373

5515

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

183.4

10097

72291

L75

ICPC

Fracture: femur

4.3

183.2

483

1048

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.5

182.9

667

1823

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

182.5

5155

32055

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

182.0

2196

10673

J01DA01

ATC

[U] cefalexin

1.4

182.0

17197

135625

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.8

181.2

3304

18313

SPAT1211

SPAT

Application of soft bandage

1.9

180.8

2577

13248

J01MA14

ATC

moxifloxacin; systemic

1.9

180.5

2497

12712

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

180.4

2077

9928

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

180.2

4261

25349

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.6

179.9

605

1567

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

179.8

1261

4928

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

179.7

2134

10313

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

179.7

6126

39758

N30.0

ICD-10 Finland

Acute cystitis

1.6

179.4

4678

28518

R5110, ,

SPAT

2.1

178.0

1930

9025

R11

ICD-10 Finland

Nausea and vomiting

1.9

177.5

2524

12961

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

177.1

3088

16888

M81

ICD-10 Finland

Osteoporosis without pathological fracture

6.4

176.5

302

444

S72.4

ICD-10 Finland

Fracture of lower end of femur

5.3

176.1

366

650

JN4AD

NOMESCO Finland

Body CT examination

1.8

175.7

2787

14812

N05BA04

ATC

oxazepam; oral

1.5

175.4

7169

48318

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

174.6

1839

8506

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

174.2

19769

160423

M01AH02

ATC

rofecoxib; oral

1.7

173.4

3614

20779

NH3BG

NOMESCO Finland

MRI of foot

6.7

173.3

285

402

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

173.0

1457

6168

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.1

172.9

735

2210

J04AB02

ATC

rifampicin; systemic

4.2

172.4

473

1058

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

172.2

7937

54769

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

171.9

2221

11044

L16

ICPC

Ankle symptom/complaint

1.7

170.7

3193

17809

M93.1

ICD-10 Finland

Kienböck disease of adults

541.8

170.7

174

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

3.5

170.2

598

1595

TK800

NOMESCO Finland

Hemodialysis

3.2

170.0

688

2008

A10AB05

ATC

insulin aspart; parenteral

2.0

169.9

2132

10496

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

169.2

1461

6248

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

169.0

5339

34004

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

168.7

2572

13495

J01EA01

ATC

trimethoprim; systemic

1.5

168.5

7373

50314

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

4.6

168.3

407

824

R42

ICD-10 Finland

Dizziness and giddiness

1.5

167.7

6375

42264

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

167.3

925

3218

NGQ20

NOMESCO Finland

Amputation of lower leg

7.3

167.0

253

326

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

166.8

11889

88747

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.7

165.7

914

3176

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

165.5

1058

3957

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.6

165.2

1044

3883

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

164.4

6335

42090

N06AX16

ATC

venlafaxine; oral

1.7

164.3

3818

22566

ZXE00

NOMESCO Finland

One hour or less

1.4

164.0

10486

76735

H3603, E103,

ICD-10 Finland

4.9

163.5

375

726

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.1

163.5

710

2161

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.4

162.7

1153

4525

M86.0

ICD-10 Finland

Acute haematogenous osteomyelitis

+∞

162.3

160

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

162.2

4807

30141

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.6

162.1

560

1477

M01AC06

ATC

meloxicam; systemic, rectal

1.4

161.4

9867

71580

M94.8

ICD-10 Finland

Other specified disorders of cartilage

24.7

160.8

119

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

160.7

3196

18116

WZC30

NOMESCO Finland

Teaching

1.6

160.7

4203

25577

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

160.7

2787

15195

M03BX02

ATC

tizanidine; oral

1.4

159.5

16960

134996

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.3

159.4

623

1779

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

4.4

158.9

408

867

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

158.6

3891

23302

M86.2

ICD-10 Finland

Subacute osteomyelitis

1527.0

158.1

158

SPAT1234

SPAT

Support of social functional capacity

2.2

158.1

1507

6703

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

9.4

157.8

195

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

157.4

2192

11163

J01AA02

ATC

doxycycline; systemic

1.4

157.3

21758

180919

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

13.7

157.1

152

104

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.0

156.4

727

2302

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.5

156.3

1056

4053

NGF40

NOMESCO Finland

Repair of defect of cartilage in the knee joint with transplant

15.8

156.1

140

A11CC03

ATC

alfacalcidol; systemic

2.9

155.0

738

2368

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.5

154.6

308

526

NDJ86

NOMESCO Finland

Late fixation of fracture of hand or wrist to promote bone formation

17.4

154.3

132

M01CB01

ATC

sodium aurothiomalate; parenteral

3.7

154.2

504

1280

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

154.2

5974

39662

J01FA06

ATC

roxithromycin; oral

1.4

153.6

10707

79281

NFB60

NOMESCO Finland

Demanding prosthetic replacement of hip

7.2

153.3

234

304

A02BA02

ATC

ranitidine; systemic

1.5

153.3

5163

33268

ZXA10

NOMESCO Finland

Bilateral

1.5

152.9

5076

32604

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.6

152.5

898

3225

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

152.3

2451

13059

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.8

152.0

353

691

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.7

151.9

845

2948

S72.2

ICD-10 Finland

Subtrochanteric fracture

5.1

151.8

330

610

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

151.6

7078

48737

M94.1

ICD-10 Finland

Relapsing polychondritis

73.9

151.6

L15

ICPC

Knee symptom/complaint

1.5

151.2

6498

44027

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.5

151.0

1002

3813

J01CF05

ATC

flucloxacillin; systemic

2.0

150.2

1683

7951

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

150.0

1671

7878

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

149.3

3749

22554

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

5.1

148.9

323

596

T92.2

ICD-10 Finland

Sequelae of fracture at wrist and hand level

4.9

148.8

341

660

N05AH04

ATC

quetiapine; oral

1.6

148.7

4589

28982

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.7

148.4

845

2983

A04

ICPC

Weakness/tiredness general

1.6

147.9

4041

24808

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

147.3

5387

35291

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

145.9

2018

10245

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

11.9

145.9

153

120

M01AE02

ATC

naproxen; oral, rectal

1.4

145.8

15425

121862

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.3

145.3

565

1608

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

145.3

8171

58152

L84

ICD-10 Finland

Corns and callosities

2.4

145.3

1037

4081

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

145.0

3324

19533

B01AB10

ATC

tinzaparin; parenteral

1.7

145.0

2718

15131

B01AA03

ATC

warfarin; systemic

1.5

144.9

4830

31010

P01AB01

ATC

metronidazole; oral, rectal

1.4

144.5

10725

80021

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.9

144.2

1846

9134

J01XX08

ATC

linezolid; systemic

5.8

144.1

270

435

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.9

144.1

1929

9689

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

143.7

2463

13361

M84.9

ICD-10 Finland

Disorder of continuity of bone, unspecified

70.5

143.6

A07AA02

ATC

nystatin; oral

2.0

143.3

1705

8227

A12AA04

ATC

calcium carbonate; oral

3.5

142.9

508

1365

SPAT1260

SPAT

Consultation of another employee

1.5

142.7

4808

30931

S70.0

ICD-10 Finland

Contusion of hip

2.3

142.6

1130

4656

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

142.2

3619

21823

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.8

142.0

756

2577

NGJ86

NOMESCO Finland

Late operation of fracture of lower leg to promote bone formation

18.4

141.6

118

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.9

141.5

323

623

WX204

NOMESCO Finland

Axillary plexus blockaced

2.5

141.3

946

3614

M83.2

ICD-10 Finland

Adult osteomalacia due to malabsorption

667.8

141.1

143

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

141.1

2280

12151

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

6.3

140.7

245

367

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

140.3

1837

9156

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

139.8

3638

22051

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

139.6

2222

11785

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

139.4

7072

49330

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

138.6

10162

75522

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.9

138.5

420

1012

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

138.4

771

2691

L11

ICPC

Wrist symptom/complaint

1.8

138.0

2428

13264

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

138.0

1442

6636

72299

ICD-8 Finland

Unspecified forms of osteochondrosis

+∞

137.9

136

ZZH31

NOMESCO Finland

Bone allograft, small pieces

4.7

137.9

325

644

A10AC01

ATC

insulin (human); parenteral

1.9

137.9

1979

10162

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

137.7

1551

7337

N05BA01

ATC

diazepam; systemic, rectal

1.6

137.5

3501

21102

M01AX17

ATC

nimesulide; oral

1.5

137.1

6368

43669

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

136.8

2302

12413

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.6

136.6

835

3054

NA2AD

NOMESCO Finland

Thoracic spine CT examination

5.5

136.5

269

455

R02

ICPC

Shortness of breath/dyspnoea

1.6

136.2

3505

21176

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

136.0

1031

4166

L12

ICPC

Hand/finger symptom/complaint

1.5

135.8

4300

27258

J01CA08

ATC

pivmecillinam; oral

1.4

135.7

11205

84802

W10

ICD-10 Finland

Fall on and from stairs and steps

2.1

135.6

1452

6743

M77.4

ICD-10 Finland

Metatarsalgia

2.0

135.2

1652

8040

NDG30

NOMESCO Finland

Fusion of wrist, total

6.2

135.0

236

355

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

10.4

134.8

155

140

NGU20

NOMESCO Finland

Removal of internal fixation device from knee or lower leg

3.2

134.7

558

1651

M92.7

ICD-10 Finland

Juvenile osteochondrosis of metatarsus

169.6

134.6

145

M01AB05

ATC

diclofenac; systemic, rectal

1.4

134.6

18017

146756

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

134.0

1120

4719

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

133.8

1017

4114

L04AD01

ATC

ciclosporin; systemic

3.1

133.0

585

1794

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

132.8

9015

66043

I50.0

ICD-10 Finland

Congestive heart failure

1.9

132.6

1918

9871

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

132.5

855

3209

Z94.0

ICD-10 Finland

Kidney transplant status

4.0

132.5

394

936

C03DA01

ATC

spironolactone; oral

1.6

132.4

3156

18702

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

132.3

2162

11551

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.7

131.8

751

2652

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

131.6

1247

5526

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

131.3

5827

39567

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.8

131.0

301

584

R06AE07

ATC

cetirizine; oral

1.4

130.5

11855

90884

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.2

130.3

542

1608

S06.0

ICD-10 Finland

Concussion

1.7

130.2

2885

16779

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

129.5

3654

22546

NGK05

NOMESCO Finland

Partial or total excision of bone of lower leg

23.8

129.3

C08CA01

ATC

amlodipine; oral

1.4

129.3

10006

74790

1220

FHL

Arthroscopy

2.3

129.0

1081

4558

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

129.0

780

2837

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.6

127.9

313

640

NDK30

NOMESCO Finland

Osteotomi and rotation of a bone of hand or wrist

12.4

127.8

131

NGF30

NOMESCO Finland

Fixation of loose body of joint of knee

15.3

127.3

116

JN4BD

NOMESCO Finland

Extensive body CT

1.7

127.1

2706

15567

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

126.9

1207

5356

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.9

126.9

635

2094

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.6

126.7

429

1116

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

126.6

604

1940

NBJ62

NOMESCO Finland

Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus

3.5

126.3

440

1167

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.9

126.0

603

1940

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

126.0

1540

7493

N05CD07

ATC

temazepam; oral

1.6

125.2

3131

18761

WX892

NOMESCO Finland

Monitored bed care

1.8

124.9

1990

10545

NHF25

NOMESCO Finland

Operation for debridement of ankle joint, arthroscopic

4.3

124.7

334

734

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

124.6

1156

5080

M87.8

ICD-10 Finland

Other osteonecrosis

245.7

124.5

131

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

124.5

10239

77143

M89.88

ICD-10 Finland

Other specified disorders of bone, other

50.7

124.4

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

124.1

6506

45490

N06AB04

ATC

citalopram; systemic

1.5

124.1

5493

37227

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

123.2

3250

19722

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

122.3

847

3286

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

122.2

2304

12819

NBJ86

NOMESCO Finland

Late operation of shoulder or upper arm to promote bone formation

18.5

121.5

101

Z71.8

ICD-10 Finland

Other specified counselling

1.4

121.3

8002

58153

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.0

120.9

355

836

NHS20

NOMESCO Finland

Incision and debridement of infection of bone of ankle or foot

35.6

120.8

M19.2

ICD-10 Finland

Other secondary arthrosis

3.4

120.6

444

1221

M91.1

ICD-10 Finland

Juvenile osteochondrosis of head of femur [Legg-Calvé-Perthes]

384.5

120.4

124

L04AD02

ATC

tacrolimus; systemic

4.0

119.7

354

838

R07.3

ICD-10 Finland

Other chest pain

1.7

119.6

2697

15737

S42.3

ICD-10 Finland

Fracture of shaft of humerus

3.6

119.4

402

1042

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.8

119.3

620

2086

R52.1

ICD-10 Finland

Chronic intractable pain

4.2

118.9

329

741

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

118.8

2675

15601

J46

ICD-10 Finland

Status asthmaticus

2.4

118.6

836

3269

L08

ICPC

Shoulder symptom/complaint

1.4

118.6

5642

38716

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

118.0

3576

22389

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

117.9

1649

8387

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

117.8

2541

14654

A10AB01

ATC

insulin (human); parenteral

2.3

117.7

922

3778

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

117.4

2876

17128

SPAT1262

SPAT

Handing over of treatment supplies

1.5

117.4

4446

29184

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

375.1

117.3

121

J02AC01

ATC

fluconazole; systemic

1.3

117.3

10364

78739

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.4

117.3

872

3492

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.8

117.1

621

2112

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

116.9

10315

78338

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.2

116.4

1038

4488

G44.2

ICD-10 Finland

Tension-type headache

1.6

116.4

3544

22209

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

8.2

116.0

159

182

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.7

115.8

639

2219

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

115.7

2273

12784

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

115.6

1165

5283

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.2

115.6

474

1394

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

115.6

949

3966

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

115.3

1496

7423

SPAT1210

SPAT

Application of cast or individual aid

2.1

114.5

1164

5297

L02

ICPC

Back symptom/complaint

1.7

114.5

2588

15103

9254

FHL

Arthrotomy (includes biopsy, revision, loose removal, fixation, and similar procedures)

4.6

114.3

280

573

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.4

114.2

418

1145

NF1DA

NOMESCO Finland

X-ray of hips

2.7

114.1

645

2268

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

113.8

16051

130158

C90.0

ICD-10 Finland

Multiple myeloma

3.8

113.4

355

875

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

113.4

961

4070

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.5

113.4

284

592

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.7

113.2

652

2314

M02AA10

ATC

ketoprofen; topical

1.5

113.2

4180

27280

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

113.2

5823

40480

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

113.1

4605

30647

A10AE04

ATC

insulin glargine; parenteral

1.7

113.0

2421

13931

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

112.4

2166

12113

RJ414, ,

NOMESCO Finland

9.7

112.3

135

130

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.5

112.3

709

2633

ZZH40

NOMESCO Finland

Substitute of bone

3.9

112.3

334

794

S82.2

ICD-10 Finland

Fracture of shaft of tibia

3.2

112.2

471

1405

Y96.9

ICD-10 Finland

Unspecified type of accident

2.9

112.1

559

1840

V03AE01

ATC

polystyrene sulfonate; oral

3.5

111.9

402

1088

N03AX09

ATC

lamotrigine; oral

2.0

111.8

1217

5679

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

111.7

2495

14510

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

111.5

954

4055

M22.4

ICD-10 Finland

Chondromalacia patellae

2.4

111.5

813

3227

Z50.1

ICD-10 Finland

Other physical therapy

1.9

111.5

1445

7165

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.3

111.4

426

1200

NB1AD

NOMESCO Finland

Shoulder CT examination

3.0

111.2

511

1607

QD6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in foot

10.4

111.0

127

114

WX402

NOMESCO Finland

General anaesthesia

1.4

110.6

5353

36785

S42.0

ICD-10 Finland

Fracture of clavicle

2.4

110.6

782

3062

UKC02

NOMESCO Finland

Cystoscopy

1.5

110.5

3805

24466

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

2.1

110.4

1100

4966

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.7

110.4

631

2231

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

4.5

110.4

274

567

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

110.4

1681

8778

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

109.7

1369

6701

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

109.7

2052

11379

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

3.2

109.4

439

1274

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.5

109.2

686

2541

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.1

108.9

1116

5092

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

108.8

2189

12382

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.2

108.8

444

1302

M88.9

ICD-10 Finland

Paget disease of bone, unspecified

+∞

108.5

107

72222

ICD-8 Finland

Osteochondrosis, Tuberositatis tibiae (Schlatter)

+∞

108.5

107

L14

ICPC

Leg/thigh symptom/complaint

1.7

108.5

2108

11813

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

108.4

1846

9966

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

108.4

3305

20695

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

108.1

2860

17335

L86

ICPC

Back syndrome with radiating pain

1.8

107.9

1605

8319

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

4.3

107.7

282

609

M43.1

ICD-10 Finland

Spondylolisthesis

2.1

107.6

1110

5077

72209

ICD-8 Finland

Osteochondrosis, spinalis juvenilis (Scheuermann) NUD

+∞

107.5

106

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

107.5

4524

30270

NHG20

NOMESCO Finland

Fusion of talocrural joint

4.8

107.5

246

476

A29

ICPC

General symptom/complaint other

1.5

107.4

3242

20252

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.7

107.3

609

2145

J01CA04

ATC

amoxicillin; systemic

1.4

107.1

22783

194981

ECB20

NOMESCO Finland

Oral alveoplasty

3.9

106.8

328

798

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.9

106.7

504

1610

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.2

106.5

441

1305

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.7

106.3

582

2013

R03DC03

ATC

montelukast; oral

1.5

106.3

4225

27951

L29

ICPC

Musculoskeletal sympt/complt other

1.7

105.8

2246

12883

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

3.4

105.6

396

1102

72399

ICD-8 Finland

Other diseases of bone

+∞

105.5

104

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.0

105.4

1193

5644

M14.6

ICD-10 Finland

Neuropathic arthropathy

15.2

105.1

M01AX05

ATC

glucosamine; oral

1.4

104.7

5108

35112

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

104.1

2954

18189

NDG20

NOMESCO Finland

Fusion of wrist, partial

5.2

103.9

221

401

R03BA05

ATC

fluticasone; inhalant

1.4

103.8

4685

31740

T93.2

ICD-10 Finland

Sequelae of other fractures of lower limb

3.6

103.8

349

904

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.1

103.5

435

1299

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.7

103.4

562

1936

7324B

ICD-9 Finland

Osteochondropathies, Juvenile osteochondrosis of lower extremity, excluding foot[OSTEOCHONDROSIS JUVENILIS TUBEROSITATIS TIBIAE]

+∞

103.4

102

A07AA09

ATC

vancomycin; oral

3.1

103.3

441

1329

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.0

103.2

297

689

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

103.1

919

3971

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

4.8

103.0

239

468

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

3.2

102.9

431

1284

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

102.7

2312

13461

M87.2

ICD-10 Finland

Osteonecrosis due to previous trauma

203.7

102.6

109

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.1

102.6

1003

4495

SPAT1325

SPAT

Vaccination

1.3

102.5

8638

64841

SPAT1310

SPAT

Counselling related to known health issue

1.3

102.4

8212

61187

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

102.3

6055

43010

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.8

102.3

525

1755

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

102.2

1884

10399

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

102.0

2664

16087

ZXD35

NOMESCO Finland

Usual procedure

2.2

101.4

898

3870

M86

ICD-10 Finland

Osteomyelitis

40.4

101.3

D07AC01

ATC

betamethasone; topical

1.3

100.8

9287

70577

N03AE01

ATC

clonazepam; systemic

1.8

100.8

1476

7610

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

2.1

100.7

1021

4639

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

100.6

17771

147343

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

100.4

1046

4800

M01AB55

ATC

diclofenac, combinations; oral

1.8

100.1

1774

9683

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.0

99.8

452

1410

NF3AD

NOMESCO Finland

Femur CT

7.9

99.8

140

165

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

99.7

1551

8145

S82.1

ICD-10 Finland

Fracture of upper end of tibia

2.8

99.7

529

1800

M54

ICD-10 Finland

Dorsalgia

1.5

99.5

3100

19477

A08

ICPC

Swelling

1.9

99.5

1343

6745

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.3

99.5

806

3349

72288

ICD-8 Finland

Other specified forms of osteochondrosis

+∞

99.4

S20

ICPC

Corn/callosity

2.6

99.3

585

2100

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.0

98.9

1079

5037

M79.1

ICD-10 Finland

Myalgia

1.5

98.6

3617

23520

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.9

98.5

467

1495

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

98.2

1021

4682

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

97.9

5941

42331

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

97.8

1668

9003

V03AE02

ATC

sevelamer; oral

5.2

97.6

205

368

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

97.4

1185

5747

7339X

ICD-9 Finland

Other disorders of bone and cartilage, Other and unspecified disorders of bone and cartilage

+∞

97.3

A01AB09

ATC

miconazole; local oral

1.6

97.3

2287

13454

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.9

96.6

464

1496

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

96.5

1609

8626

T89

ICPC

Diabetes insulin dependent

2.1

96.4

985

4487

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

95.9

2391

14267

K59.0

ICD-10 Finland

Constipation

1.8

95.9

1481

7759

L04AB04

ATC

adalimumab; parenteral

2.6

95.9

595

2191

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

95.9

5202

36361

S29

ICPC

Skin symptom/complaint other

1.4

95.7

4856

33547

L99

ICPC

Musculoskeletal disease other

2.5

95.7

613

2292

B01AF01

ATC

rivaroxaban; oral

1.5

95.6

3141

19953

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

95.5

1499

7892

7327X

ICD-9 Finland

Osteochondropathies, Osteochondritis dissecans[OSTEOCHONDRITIS DISSECANS ALIA LOCO DEFINITO]

+∞

95.3

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

95.3

1451

7569

S52.0

ICD-10 Finland

Fracture of upper end of ulna

2.7

95.2

524

1817

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

95.2

2570

15628

L04AB01

ATC

etanercept; parenteral

2.9

95.1

463

1504

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

95.1

6609

48083

S76

ICPC

Skin infection other

1.9

94.8

1355

6929

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

94.7

1045

4898

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.4

94.6

668

2613

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.6

94.6

2188

12816

N02AC04

ATC

dextropropoxyphene; oral

2.1

94.5

958

4351

M54.8

ICD-10 Finland

Other dorsalgia

1.9

94.5

1170

5708

WX214

NOMESCO Finland

Plexus blockade at the ankle

4.6

94.4

230

469

N18.8

ICD-10 Finland

Other chronic renal failure

2.4

94.3

651

2521

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.4

94.1

661

2580

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

94.0

1381

7124

NFK99

NOMESCO Finland

Other operation on bone of femur

19.7

94.0

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

93.9

729

2974

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.7

93.9

541

1921

NG1AD

NOMESCO Finland

Knee CT examination

2.9

93.7

462

1511

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

3.3

93.7

359

1013

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

93.6

1416

7371

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

93.5

1453

7626

SPAT1172

SPAT

Guidance concerning hydration

2.4

93.4

651

2532

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

2.8

93.3

489

1653

R03AC12

ATC

salmeterol; inhalant

1.9

93.0

1159

5667

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

93.0

1333

6823

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

93.0

775

3258

T92.1

ICD-10 Finland

Sequelae of fracture of arm

4.6

92.9

227

464

ZZH20

NOMESCO Finland

Graft of patients own bone

5.9

92.9

170

268

B01AB04

ATC

dalteparin; parenteral

1.8

92.9

1365

7042

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.0

92.7

267

620

R13

ICD-10 Finland

Dysphagia

1.7

92.5

1705

9404

S80.0

ICD-10 Finland

Contusion of knee

1.7

92.4

1891

10729

H26.4

ICD-10 Finland

After-cataract

1.6

92.3

2552

15596

72000

ICD-8 Finland

Osteomyelitis and periostitis, Acute osteomyelitis

+∞

92.3

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

92.3

3648

24051

E87.6

ICD-10 Finland

Hypokalaemia

2.1

92.2

909

4086

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

92.1

2372

14259

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

92.0

1226

6129

327

Kela drug reimbursment

strontium ranelate

23.8

91.9

N18.0

ICD-10 Finland

End-stage renal disease

3.5

91.8

321

854

ND1AD

NOMESCO Finland

Wrist CT examination

3.4

91.6

337

927

NH2AA

NOMESCO Finland

Heel X-ray examination

4.5

91.5

231

485

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.4

91.4

639

2488

B01AC04

ATC

clopidogrel; oral

1.5

91.4

3826

25499

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

91.4

14426

117223

A10AA01, ,

ATC

2.4

91.3

659

2604

K07

ICPC

Swollen ankles/oedema

1.9

91.0

1194

5939

A04AA01

ATC

ondansetron; systemic, rectal

1.6

90.9

2030

11782

153

Kela drug reimbursment

Lenalidomid

4.8

90.8

208

403

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

90.7

1289

6578

L04AX04

ATC

lenalidomide; oral

4.9

90.3

203

387

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

90.2

1644

9037

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

90.2

1669

9214

R03DA04

ATC

theophylline; systemic, rectal

1.9

89.8

1258

6391

R4110, ,

SPAT

1.6

89.7

2178

12906

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

6.4

89.5

153

225

NGK99

NOMESCO Finland

Other operation on bone of knee or lower leg

12.3

89.4

RS221, ,

NOMESCO Finland

3.0

89.4

420

1338

S52.6

ICD-10 Finland

Fracture of lower end of both ulna and radius

2.5

89.1

578

2174

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

89.1

1348

7015

Z00.0

ICD-10 Finland

General medical examination

1.4

89.0

4869

34031

NDA30

NOMESCO Finland

Exploration of joint of wrist or hand, arthroscopic

3.8

88.8

278

686

NHG22

NOMESCO Finland

Fusion of subtalar joint

4.2

88.6

243

544

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

88.6

2595

16062

S20.2

ICD-10 Finland

Contusion of thorax

1.8

88.6

1303

6722

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.5

88.5

220

456

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

88.4

4668

32427

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

88.1

1082

5264

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.3

88.0

694

2850

A10AA02, ,

ATC

2.1

87.8

822

3621

L05

ICPC

Flank/axilla symptom/complaint

1.8

87.7

1506

8139

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

87.6

6667

49074

9165

FHL

Removal of osteosynthesis material

2.6

87.6

546

2015

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

87.6

5026

35399

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.7

87.4

1804

10256

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

6.7

87.4

143

201

M79.7

ICD-10 Finland

Fibromyalgia

2.1

87.3

904

4138

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

3.3

87.2

333

938

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

87.2

1040

5009

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

87.1

2223

13328

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

87.1

1249

6393

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.3

87.0

341

976

R55

ICD-10 Finland

Syncope and collapse

1.5

86.9

2740

17231

J01DA09

ATC

[U] cefadroxil

1.3

86.8

6599

48556

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

86.8

704

2926

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

86.5

1571

8624

NHF30

NOMESCO Finland

Fixation of loose fragment from ankle joint

33.8

86.3

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

86.2

12085

96507

R52.0

ICD-10 Finland

Acute pain

2.1

86.0

849

3817

NFJ86

NOMESCO Finland

Late operation for fracture of femur to promote bone formation

25.6

86.0

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

85.9

1052

5112

M23.8

ICD-10 Finland

Other internal derangements of knee

2.0

85.8

931

4336

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

85.7

1395

7420

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

85.5

2168

12975

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

85.4

5287

37680

M88.88

ICD-10 Finland

Paget disease of other bones, other

+∞

85.2

S32.5

ICD-10 Finland

Fracture of pubis

3.6

85.0

293

772

Y94.0

ICD-10 Finland

Accident at home

2.6

84.9

521

1908

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

84.9

1542

8465

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.1

84.9

242

558

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

84.9

5057

35814

Z01.2

ICD-10 Finland

Dental examination

1.3

84.7

11713

93310

M05BA08

ATC

zoledronic acid; parenteral

12.5

84.7

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

84.6

857

3890

R03BA01

ATC

beclometasone; inhalant

1.5

84.5

3504

23286

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.4

84.4

603

2372

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.9

84.2

1166

5900

M17.5

ICD-10 Finland

Other secondary gonarthrosis

2.9

84.2

401

1287

SPAT1312

SPAT

General health counselling

1.3

84.1

8084

61439

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

84.0

1352

7168

QDB10, ,

SPAT

2.7

83.9

468

1635

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.5

83.7

537

2010

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

83.6

1967

11559

H25.8

ICD-10 Finland

Other senile cataract

1.5

83.5

2663

16783

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.0

83.5

184

345

NCU20

NOMESCO Finland

Removal of internal fixation device from elbow or forearm

3.5

83.4

293

782

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.3

83.4

655

2685

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.5

83.4

206

425

M04AA01

ATC

allopurinol; systemic

1.5

83.4

2984

19261

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

83.4

3957

26951

WW200

NOMESCO Finland

Immunization

2.2

83.2

710

3014

H26.3

ICD-10 Finland

Drug-induced cataract

4.4

83.1

211

445

R33

ICD-10 Finland

Retention of urine

1.7

83.1

1707

9689

A03FA02

ATC

cisapride; oral, rectal

1.6

83.0

1917

11211

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.0

82.9

150

234

E83.50

ICD-10 Finland

Hypercalcemia

2.9

82.8

402

1304

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.1

82.8

349

1044

H3603, E113,

ICD-10 Finland

3.7

82.6

264

661

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

82.5

2735

17373

EBA00

NOMESCO Finland

Extraction of tooth

1.3

82.5

8904

68684

S82.0

ICD-10 Finland

Fracture of patella

2.7

82.4

473

1676

ZZH22

NOMESCO Finland

Graft of patients own bone, block

4.9

82.3

187

360

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

4.0

82.2

237

551

K08.3

ICD-10 Finland

Retained dental root

1.6

82.0

1840

10683

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

81.7

1214

6281

C01DA14

ATC

isosorbide mononitrate; oral

1.4

81.7

3604

24218

S32.1

ICD-10 Finland

Fracture of sacrum

3.9

81.5

243

579

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

81.5

19156

162278

M85.0

ICD-10 Finland

Fibrous dysplasia (monostotic)

764.6

81.3

K02.1

ICD-10 Finland

Caries of dentine

1.3

81.1

15220

125503

A10AB04

ATC

insulin lispro; parenteral

2.1

81.1

762

3361

7328A

ICD-9 Finland

Osteochondropathies, Other specified forms of osteochondropathy[JALKATERÄN YLIMÄÄRÄISTEN LUIDEN AIHEUTTAMAT OIREET]

+∞

81.1

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

80.9

1154

5895

ZXD20

NOMESCO Finland

Day surgery

1.5

80.8

3180

20906

R03BA02

ATC

budesonide; inhalant

1.4

80.7

4439

30996

NHS99

NOMESCO Finland

Other operation for infection of tendon, joint or bone of ankle or foot

10.0

80.6

Y94.8

ICD-10 Finland

Other leisure activity accident

2.2

80.6

713

3071

7328B

ICD-9 Finland

Osteochondropathies, Other specified forms of osteochondropathy[MUIDEN YLIMÄÄRÄISTEN LUIDEN AIHEUTTAMAT OIREET]

+∞

80.1

RF210, ,

NOMESCO Finland

2.2

80.0

719

3117

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

3.9

79.9

238

567

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

79.7

3345

22258

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.7

79.5

1430

7827

W17

ICD-10 Finland

Other fall from one level to another

1.9

79.0

1039

5169

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

5.8

79.0

149

242

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

79.0

3063

20074

B01AF02

ATC

apixaban; oral

1.5

79.0

3009

19653

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.6

78.9

190

384

TGC00

NOMESCO Finland

Bronchial lavation

2.3

78.8

651

2727

SPAT1167

SPAT

Insertion of urinary catheter

2.1

78.7

763

3406

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.5

78.5

524

1998

137

Kela drug reimbursment

Uraemia requiring dialysis

3.6

78.4

261

672

NFJ50

NOMESCO Finland

Internal fixation of fracture of neck of femur with nail or screw

4.7

78.4

187

375

S82.3

ICD-10 Finland

Fracture of lower end of tibia

2.4

78.4

533

2050

Z51.5

ICD-10 Finland

Palliative care

1.6

78.3

1843

10825

R96

ICPC

Asthma

1.5

78.2

2375

14800

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.8

78.2

181

354

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

77.9

2669

17061

J01CF02

ATC

cloxacillin; systemic

2.3

77.8

582

2336

RJ411, ,

NOMESCO Finland

4.5

77.8

192

396

A10AE05

ATC

insulin detemir; parenteral

1.8

77.8

1290

6897

ACC51

NOMESCO Finland

Release of median nerve

1.6

77.7

1852

10911

SPAT1053

SPAT

Memory test

1.4

77.7

3396

22765

WZA00

NOMESCO Finland

Concise certificate

1.7

77.6

1557

8780

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

3.2

77.4

320

947

NGJ60

NOMESCO Finland

Internal fixation of fracture of knee or lower leg using intramedullary nail, other or unspecified

3.6

77.3

265

696

NBU20

NOMESCO Finland

Removal of internal fixation device from shoulder or upper arm

3.6

77.3

262

683

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

77.1

1442

7978

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.8

77.0

1178

6147

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

77.0

1964

11761

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

76.9

6450

48001

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.2

76.3

653

2775

J45

ICD-10 Finland

Asthma

1.5

76.2

2549

16210

NHJ86

NOMESCO Finland

Late operation or reoperation of fracture of foot or toe

9.3

76.1

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

75.9

2459

15534

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

75.7

1395

7684

M81.1

ICD-10 Finland

Postoophorectomy osteoporosis

129.2

75.6

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

4.1

75.6

216

499

NDK99

NOMESCO Finland

Other operation on bone of hand or wrist

7.4

75.6

112

141

SFA10

NOMESCO Finland

One-surface restoration

1.3

75.5

14151

116265

N04BC05

ATC

pramipexole; oral

1.6

75.4

1883

11217

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

75.4

971

4798

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.4

75.3

553

2202

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

75.3

1170

6135

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.3

75.2

286

804

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

75.0

1542

8750

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

74.8

762

3466

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

2.2

74.2

669

2904

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.9

73.9

362

1181

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.0

73.8

785

3628

Z49.2

ICD-10 Finland

Other dialysis

3.9

73.8

222

533

WVA30, ,

SPAT

1.8

73.7

1277

6913

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

73.6

689

3035

E87.5

ICD-10 Finland

Hyperkalaemia

2.5

73.6

461

1706

G03CA04

ATC

estriol; systemic, vaginal

1.6

73.5

1828

10879

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

73.4

892

4322

NG2AA

NOMESCO Finland

Patella X-ray examination

2.1

73.3

719

3224

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

73.3

415

1461

NCJ62

NOMESCO Finland

Internal fixation of fracture of forearm using plate

2.3

73.3

573

2345

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

3.4

73.1

268

736

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.5

72.9

472

1774

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001122) Ferritin [Mass/volume] in Serum or Plasma

13789

97218

1.59

319.53

3.7

2.8

135.64

125.97

ug/l

3.40

12732

89788

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4655

24628

1.90

309.61

7.7

7.0

5.12

5.09

kpa

1.34

4429

23496

(3028026) IgM [Mass/volume] in Serum or Plasma

2847

12612

2.22

308.13

2.3

1.8

1.28

1.33

g/l

0.55

2560

11495

(3027801) Oxygen [Partial pressure] in Arterial blood

4647

24615

1.90

307.78

7.7

7.0

11.90

12.55

kpa

14.08

4418

23476

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10896

68079

1.77

307.65

2.5

2.1

221.14

201.17

u/l

0.55

10232

63636

(3006504) Eosinophils/100 leukocytes in Blood

15969

106180

1.85

307.65

8.9

5.9

2.78

2.86

5.30

15073

98955

(3015377) Calcium [Moles/volume] in Serum or Plasma

12605

76184

1.93

307.65

4.1

3.3

2.35

2.36

mmol/l

5.54

11020

66664

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5827

29974

2.00

307.65

3.4

2.5

21.09

22.55

12.05

4907

25568

(3022096) Basophils/100 leukocytes in Blood

15595

102837

1.85

307.65

9.0

5.9

0.67

0.68

2.84

14678

95597

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12844

84886

1.71

307.65

4.9

3.4

69.31

60.15

ng/l

0.17

9493

56872

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8039

49333

1.71

307.65

2.1

1.7

1.21

1.22

mg/l

0.04

6323

37491

(3019309) Folate [Moles/volume] in Red Blood Cells

7252

41742

1.81

307.65

1.9

1.7

1238.99

1161.58

nmol/l

8.13

5557

31297

(3031040) Bacteria [#/volume] in Urine by Automated count

20221

151090

1.75

307.65

6.3

4.4

2180.20

1537.64

e6/l

0.61

306

2048

(3001604) Monocytes [#/volume] in Blood

17090

113025

1.94

307.65

8.5

5.7

0.60

0.58

e9/l

9.65

15148

97575

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6893

35026

2.08

307.65

2.2

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4533

17079

2.73

307.65

3.1

2.5

66.11

66.49

g/l

2.54

4026

15486

(3004588) Protein electrophoresis panel - Serum or Plasma

4013

13821

2.97

307.65

2.8

2.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

16328

93354

2.37

307.65

3.3

2.2

79.87

1059.10

nmol/l

0.50

14880

83519

(3005719) IgG [Mass/volume] in Serum or Plasma

3580

16243

2.19

307.65

3.7

2.6

10.15

10.59

g/l

6.29

3267

14869

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17362

117644

1.88

307.65

7.9

5.9

10.62

11.32

umol/l

10.12

16541

111306

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

12130

80309

1.68

307.65

4.5

3.2

—

0.28

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18603

112274

2.42

307.65

10.7

6.2

1.22

mmol/l

4.80

15919

95101

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2127

6210

3.36

307.65

4.0

3.1

39.19

45.36

mg/l

0.79

1659

5082

(3027945) Reticulocytes/100 erythrocytes in Blood

4897

24114

2.06

307.65

3.2

2.5

1.86

1.76

8.33

4329

21268

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3672

16030

2.29

307.65

1.9

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

603

202

28.35

307.65

1.7

1.3

0.36

0.48

ug/l

2.84

436

106

(3026008) Bacteria identified in Urine by Culture

11277

71078

1.76

307.65

4.1

3.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

23569

175554

2.15

307.65

11.3

7.2

80.47

78.34

u/l

7.58

22606

164876

(3037756) Immunofixation for Serum or Plasma

1382

4122

3.22

307.65

2.0

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6611

27890

2.55

307.65

7.8

5.5

1.05

1.04

mmol/l

0.12

6150

25878

(3018418) pH of Serum or Plasma

11791

66385

2.07

307.65

6.5

3.8

7.40

3.88

2580

12268

(3006315) Basophils [#/volume] in Blood

17122

113303

1.94

307.65

8.5

5.7

0.04

e9/l

0.66

15171

97727

(40760892) CBC W Ordered Manual Differential panel - Blood

16484

106150

1.99

307.65

9.2

6.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4379

19780

2.24

307.65

2.4

2.2

336.18

382.23

nmol/l

32.86

4033

18143

(40760888) Immunoglobulin light chains.free panel - Serum

1668

4649

3.48

307.65

4.0

3.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

16291

109807

1.83

307.65

9.1

5.9

26.56

28.12

59.69

15403

102799

(3018010) Neutrophils/100 leukocytes in Blood

16069

108157

1.82

307.65

8.7

5.8

58.40

57.06

36.73

15182

101150

(3022217) INR in Platelet poor plasma by Coagulation assay

15944

104052

1.91

307.65

17.7

14.4

1.24

1.26

inr

1.38

4592

30014

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4835

23953

2.05

307.65

2.1

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

20811

157593

1.74

307.65

6.2

4.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11223

71399

1.74

307.65

3.3

2.5

57.04

63.40

u/l

2.85

10401

65712

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4809

24036

2.03

307.65

2.1

1.7

—

(3013115) Eosinophils [#/volume] in Blood

17544

117090

1.95

307.65

8.8

5.9

0.19

e9/l

0.77

15650

102429

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4611

16015

2.99

307.65

4.5

3.7

93.69

88.76

ng/l

1.96

3964

13754

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17077

101753

2.30

307.65

9.3

5.6

1.22

1.21

mmol/l

8.60

15895

92384

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2078

6033

3.37

307.65

3.9

3.1

4.89

3.73

ratio

0.16

186

449

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15537

105799

1.76

307.65

3.2

2.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

15661

97539

2.03

307.65

6.7

4.6

34.71

35.61

g/l

70.78

14629

90236

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13351

92867

1.61

307.65

2.3

2.0

95.41

96.63

pmol/l

2.11

7201

47281

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2106

7960

2.57

307.65

2.9

2.1

7.55

7.39

g/l

3.75

1835

7146

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9668

55522

1.92

307.65

2.7

2.2

3.09

2.95

mg/l

5.97

8355

47297

(3042936) Bacteria identified in Isolate by Culture

6601

30459

2.30

307.65

2.9

1.9

—

(3023368) Bacteria identified in Blood by Culture

10829

58767

2.12

307.65

5.9

4.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

5479

25882

2.19

307.65

2.4

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10169

63403

1.75

307.65

3.5

2.9

1706.11

1365.13

ng/l

8.95

8761

53899

(3022948) Iron [Moles/volume] in Serum or Plasma

6584

34758

1.98

307.65

3.3

2.4

11.90

13.71

umol/l

2.61

6109

32262

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4862

24694

1.99

307.65

4.4

4.2

239.76

244.36

u/l

1.58

4584

23283

(3021960) Folate [Moles/volume] in Serum or Plasma

8503

51463

1.75

307.65

1.7

1.5

20.86

20.59

nmol/l

0.60

7300

43884

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8660

54156

1.69

307.65

3.0

2.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

22725

169119

2.02

307.65

6.2

3.9

14.85

12.11

mm/h

112.34

21320

156058

(3044640) Blood type and Crossmatch panel - Blood

11180

71231

1.73

307.65

3.1

2.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

18815

132595

1.86

307.65

6.8

4.5

6.73

6.70

mmol/l

0.92

17998

123692

(3010838) Calcium [Moles/time] in 24 hour Urine

1416

3648

3.74

307.65

1.9

4.87

5.15

mmol/24h

2.12

1208

3241

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2102

7933

2.58

307.65

2.9

2.1

3.63

3.70

g/l

1.13

1833

7126

(3034860) Kappa light chains.free [Mass/volume] in Serum

2132

6223

3.36

307.65

4.0

3.1

52.08

73.98

mg/l

0.96

1659

5091

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2103

7949

2.57

307.65

2.9

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

7345

43059

1.78

307.65

1.8

1.4

2.46

2.40

g/l

1.32

4516

25664

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6154

32042

1.99

307.65

3.3

2.4

2.28

2.35

g/l

20.15

5685

29525

(3019069) Monocytes/100 leukocytes in Blood

16029

106785

1.85

307.65

9.4

6.2

8.65

8.55

3.43

15155

99683

(3019198) Lymphocytes [#/volume] in Blood

17397

116442

1.93

307.65

8.6

5.7

1.85

1.94

e9/l

6.72

15640

102795

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6677

35758

1.95

307.65

4.5

3.3

0.81

0.82

mmol/l

13.11

6198

33370

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

342

128

25.15

307.65

1.8

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

18978

131157

1.94

307.65

12.2

8.8

4.27

4.08

e9/l

17.63

16984

114101

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

911

353

24.75

307.65

2.1

64.24

60.76

ug/l

0.35

891

344

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

8240

49676

1.75

307.65

1.4

1.3

1.41

1.69

u/ml

1.54

2270

12999

(3023520) Reticulocytes [#/volume] in Blood

3795

17821

2.12

307.65

3.1

2.5

70.88

69.66

e9/l

1.17

2948

13398

(3003396) Base excess in Arterial blood by calculation

4640

24634

1.89

304.91

7.8

7.0

1.32

1.04

mmol/l

4.45

3787

19688

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1961

7425

2.56

302.19

2.9

2.1

9.71

10.23

g/l

5.48

1676

6569

(3016502) Oxygen saturation in Arterial blood

4228

21873

1.93

300.15

8.0

7.4

95.48

95.72

1.57

4054

21071

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1967

7487

2.55

299.76

3.0

2.1

2.99

2.94

g/l

1.20

1695

6675

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1255

3779

3.18

295.71

3.4

3.1

—

(3000850) Epithelial cells [#/volume] in Urine

7599

47005

1.68

293.99

3.3

2.5

5.57

5.93

e6/l

1.68

6970

41870

(3002582) Erythrocytes [#/volume] in Urine

10179

68103

1.59

285.14

4.3

3.1

62.30

90.52

e6/l

1.26

8196

51621

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4008

20767

1.92

281.83

2.6

2.2

0.21

g/l

10.20

3690

19318

(3037522) Nuclear Ab [Titer] in Serum

5352

30376

1.78

280.86

1.5

1.3

570.14

542.41

titre

0.48

1227

6243

(3026782) Osmolality of Urine

7243

44688

1.67

280.82

3.8

2.8

514.70

538.88

mosm/kgh2o

17.57

6376

38139

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1784

6725

2.56

276.84

3.1

2.3

0.96

0.86

g/l

0.43

1468

5769

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6814

41615

1.68

273.56

3.4

3.0

2.47

2.45

mmol/l

10.98

6008

36198

(3030467) Casts [#/volume] in Urine by Automated count

9438

62543

1.59

272.41

4.1

3.1

0.40

0.42

e6/l

0.58

7562

47121

(3018095) Leukocytes [#/volume] in Urine

11528

80089

1.55

269.84

5.0

3.6

95.00

101.81

e6/l

0.33

8725

55736

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

27093

229703

1.98

269.20

25.8

13.4

22.86

23.51

mg/l

2.89

23517

180573

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2248

9588

2.28

265.05

1.9

1.7

1.59

1.54

g/l

1.34

1950

8124

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3893

20360

1.90

264.86

6.1

3.7

5.87

5.83

kpa

1.52

3755

19776

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3867

20241

1.89

262.22

8.5

7.8

117.92

121.41

g/l

21.62

3764

19701

(3020779) Urea [Moles/volume] in Serum or Plasma

3697

19085

1.92

261.45

11.7

6.9

10.61

9.68

mmol/l

10.58

3522

18136

(3002032) Base excess in Venous blood by calculation

3871

20318

1.89

260.11

6.2

3.7

1.83

1.93

mmol/l

0.83

3331

17328

(3012544) pH of Venous blood

3979

21105

1.87

258.67

6.0

3.7

7.38

0.38

152

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1225

3953

2.97

255.76

1.8

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

15122

112318

1.51

253.58

5.1

3.6

0.00

estimate

1.62

3277

22159

(3009261) Glucose [Presence] in Urine by Test strip

15251

113608

1.51

251.19

5.1

3.7

0.00

estimate

0.27

3083

20392

(3026493) Urate [Moles/volume] in Serum or Plasma

8812

58451

1.57

248.13

3.2

2.5

3312.12

4658.50

umol/l

2.84

7678

51024

(36304419) Bacteria [Presence] in Urine

9102

61030

1.56

243.33

4.1

3.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

15072

112474

1.50

242.64

6.6

4.9

0.00

estimate

0.05

3130

20839

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2679

12666

2.06

242.53

1.7

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1616

6198

2.51

241.12

2.8

2.1

37.22

37.85

g/l

3.44

1337

5370

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1969

8258

2.31

240.82

2.2

1.9

2.07

2.27

ug/l

0.30

1720

7256

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1597

6125

2.51

238.24

1.4

1.3

—

(3000991) Gas panel - Venous blood

3527

18468

1.88

237.24

10.3

7.9

—

(3017181) Myelocytes/100 leukocytes in Blood

3533

18657

1.86

231.02

5.0

4.0

0.93

0.94

0.06

1465

6120

(3002179) Metamyelocytes/100 leukocytes in Blood

3286

16976

1.90

229.94

4.7

3.8

0.65

0.69

0.51

1315

5266

(3019060) Gas panel - Arterial blood

2823

14012

1.97

222.12

4.9

4.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3574

19183

1.83

221.21

8.2

6.7

1.33

1.36

mmol/l

0.86

3489

18662

(3015736) pH of Urine

12473

90821

1.48

218.51

4.5

3.4

5.93

5.86

1.23

626

6770

(3019225) pH of Specimen

3979

22196

1.77

216.18

7.0

3.9

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5577

34104

1.64

215.64

2.7

2.1

29.83

29.77

0.33

5407

33076

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2768

13781

1.96

215.55

4.9

3.5

5.18

5.15

kpa

1.30

2602

13011

(3009343) pH of Capillary blood

2736

13604

1.96

213.79

4.9

3.5

7.42

0.39

412

1718

(3021440) Promyelocytes/100 leukocytes in Blood

3329

17786

1.84

208.32

5.1

4.0

0.09

0.12

1.84

1256

5286

(3024354) Oxygen [Partial pressure] in Venous blood

3183

16797

1.85

207.17

5.0

3.2

4.75

4.57

kpa

4.12

3051

16264

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2644

13160

1.95

205.61

4.9

3.5

1.86

1.75

mmol/l

0.72

2002

9703

(3044927) Protein electrophoresis panel - Urine

718

1911

3.56

205.11

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1500

5985

2.40

204.77

2.9

2.1

0.02

0.03

g/l

0.73

1358

5444

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1194

4274

2.67

204.65

7.8

5.4

1024.89

1385.76

iu/ml

0.31

238

593

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1019

3357

2.89

204.48

1.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

8490

57791

1.51

203.81

5.8

3.8

90.87

90.60

0.42

8277

56331

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3364

18188

1.81

202.10

6.2

3.5

1.23

mmol/l

0.88

3128

15689

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1741

7476

2.24

200.35

2.5

2.3

388.84

548.56

ug/l

1.82

1622

6992

(3025159) Blasts/100 leukocytes in Blood

3168

16878

1.84

199.55

5.1

4.1

0.25

0.29

0.13

1085

4450

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2565

12765

1.95

199.27

1.9

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

873

2680

3.09

198.36

8.0

6.0

11.79

11.63

mg/l

0.43

808

2432

(3019550) Sodium [Moles/volume] in Serum or Plasma

27209

235342

1.79

188.26

27.7

15.4

139.19

139.69

mmol/l

170.50

26763

229144

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2017

9413

2.07

187.30

1.6

1.5

14.70

14.18

u/ml

0.05

263

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2618

13392

1.90

186.77

7.3

6.9

24.83

24.60

mmol/l

2.32

2497

12754

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

21647

177774

1.48

186.64

4.7

4.1

14.99

14.79

pmol/l

25.19

19782

161419

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1380

5555

2.38

184.36

3.0

2.2

0.00

g/l

0.15

1244

5030

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6035

38938

1.55

182.08

1.4

1.3

38.39

37.57

iu/ml

0.12

1947

12382

(3023103) Potassium [Moles/volume] in Serum or Plasma

27232

235969

1.78

181.80

28.0

15.6

3.98

3.96

mmol/l

9.51

26734

229314

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1486

6234

2.28

180.40

2.1

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1306

5205

2.40

178.32

1.8

1.6

14866.28

13603.29

e6/l

0.33

962

3764

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5726

36701

1.56

177.28

1.3

17.73

12.22

u/ml

4.05

2093

14034

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1376

5634

2.34

176.72

1.6

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10246

74013

1.44

175.37

4.2

3.1

33.20

33.85

u/l

0.44

9711

69996

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6577

43580

1.52

174.48

4.7

3.6

313.11

464.81

ng/l

2.67

5183

33477

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1343

5492

2.34

172.92

3.1

2.2

0.00

g/l

-0.00

1237

5016

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5946

38638

1.54

172.40

3.4

2.7

1.26

1.22

e6/l

0.13

3537

21839

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

738

2234

3.13

171.60

1.2

46.50

29.42

nmol/l

—

(40758558) Short blood count panel - Blood

8318

57995

1.46

170.82

9.2

6.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2138

10573

1.95

168.09

7.1

4.0

24.08

24.16

mmol/l

0.53

2086

10341

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3316

18814

1.72

166.54

2.6

2.3

7.25

7.03

ug/l

0.16

2712

16352

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1596

7119

2.15

166.37

2.8

2.6

—

(3003181) Sodium [Moles/volume] in Urine

1019

3739

2.59

165.80

1.5

1.4

61.23

62.48

mmol/l

0.42

795

2978

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1503

6557

2.19

165.68

2.0

1.6

0.23

g/l

0.78

1435

6200

(3000494) Fungus identified in Specimen by Culture

4270

25916

1.62

165.47

1.7

1.4

—

(3021589) Normoblasts [#/volume] in Blood

13264

101013

1.40

164.94

15.1

9.2

0.01

0.00

e9/l

0.47

11091

82633

(3037121) Protein [Mass/volume] in Urine

1647

7509

2.10

162.12

3.2

0.39

0.31

g/l

1.28

733

3186

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

24848

211705

1.53

161.69

5.7

4.8

2.18

2.10

mu/l

0.19

22968

193976

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1527

6776

2.16

161.19

2.0

1.6

1.17

1.18

g/l

0.42

1463

6431

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1224

4958

2.35

160.89

1.8

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3791

22524

1.65

159.48

4.6

3.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6985

47671

1.47

157.72

1.8

1.7

31724589.92

32731659.89

pmol/l

0.05

5800

39140

(3014007) Fractional oxyhemoglobin in Arterial blood

2533

13625

1.80

152.46

9.9

8.8

93.68

93.95

1.48

2526

13571

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2242

11620

1.86

152.26

10.2

9.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

18554

150633

1.38

149.90

4.0

3.0

56.96

47.38

u/l

22.80

17305

140230

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1170

4794

2.32

149.66

1.9

1.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2513

13572

1.79

149.07

9.9

8.8

0.69

0.68

0.64

2495

13496

(3029937) Albumin [Presence] in Urine by Test strip

8457

60353

1.42

148.81

5.8

4.0

0.00

estimate

0.71

3026

20133

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2515

13597

1.79

148.65

9.8

8.7

1.38

0.12

2495

13510

(3017143) Hepatitis C virus Ab [Presence] in Serum

4064

25022

1.59

146.82

1.8

1.6

—

(3021788) Differential panel - Synovial fluid

1009

3951

2.43

142.88

1.7

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4146

25803

1.58

142.68

3.8

2.7

8.02

8.39

umol/l

0.45

3530

22320

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1161

4848

2.28

141.98

1.7

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1567

7375

2.03

141.16

1.7

1.6

276.53

259.67

titre

0.09

307

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5424

35931

1.49

139.64

3.7

2.8

3.04

3.14

e6/l

0.27

3042

19279

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

697

2302

2.86

138.90

1.3

1.2

68.83

61.34

u/l

1.48

635

2047

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

883

3297

2.54

138.40

3.7

2.9

1017.86

6009.53

u/ml

0.92

189

(3011397) Hemoglobin [Presence] in Urine by Test strip

7562

53460

1.42

138.18

4.9

3.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2472

13619

1.75

136.41

9.0

6.9

24.92

24.85

mmol/l

0.37

2456

13482

(40768797) Stomach Pathology biopsy report

4802

31258

1.51

133.91

1.3

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1520

7224

2.01

133.09

3.6

3.1

0.33

0.36

u/ml

2.87

882

4101

(3017704) Immunofixation for Urine

419

1037

3.80

133.07

1.8

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2382

13079

1.76

132.85

5.0

3.3

124.22

129.07

g/l

21.45

2323

12782

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2138

11373

1.81

132.81

10.0

9.0

24.50

24.32

mmol/l

1.47

2045

10985

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1444

6745

2.04

132.64

2.1

1.7

—

(3022313) Gas panel - Capillary blood

1919

9889

1.86

132.08

5.2

3.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

11369

86529

1.36

131.52

5.5

3.8

—

(3013512) EKG study

8909

65306

1.38

130.10

4.7

3.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1741

8775

1.90

128.26

1.3

1.2

1.43

0.86

u/ml

0.82

162

780

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1932

10076

1.84

127.86

4.4

2.8

1.30

1.25

1.12

1922

10025

(36660697) Celiac disease serology panel - Serum

3035

18016

1.63

126.10

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1279

5819

2.09

126.01

5.1

3.7

1.71

1.50

mg/l

13.43

1182

5336

(21494890) Protein electrophoresis panel - 24 hour Urine

620

2032

2.88

125.28

2.4

2.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

370

877

3.97

124.84

39.8

34.1

7.41

7.24

ug/l

0.68

343

785

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1884

9885

1.83

122.11

4.4

2.7

0.65

0.14

1877

9848

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

899

3588

2.37

121.87

1.9

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1300

6053

2.05

120.26

1.7

1.4

16.29

14.57

iu/ml

0.18

135

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1397

6685

1.99

119.75

1.6

0.69

8.88

iu/ml

1.77

318

1444

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1380

6576

2.00

119.70

1.5

1.4

273.31

273.47

ug/g

0.01

834

3767

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

727

2663

2.58

118.47

1.7

1.5

57.41

57.90

0.12

487

1661

(3020564) Creatinine [Moles/volume] in Serum or Plasma

27538

243296

1.63

117.60

27.6

15.6

79.12

76.19

umol/l

22.35

27532

243207

(3019150) Specific gravity of Urine by Refractometry

6915

49296

1.40

116.83

5.6

4.0

1.02

kg/l

0.48

1056

7522

(3044941) Cell count panel - Synovial fluid

845

3345

2.39

116.64

1.6

1.4

—

(40761535) Cells panel - Urine sediment

3045

18419

1.60

116.56

4.6

3.4

—

(40761511) CBC panel - Blood by Automated count

27096

238584

1.57

115.98

22.5

12.7

—

(3010375) cycloSPORINE [Mass/volume] in Blood

363

896

3.81

115.76

29.3

28.0

116.39

114.41

ug/l

0.21

290

764

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1748

9146

1.83

114.11

2.3

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

890

3646

2.31

113.61

1.6

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

634

2217

2.70

113.35

2.6

2.5

1.32

1.26

g/24h

0.20

324

1073

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1673

8680

1.84

112.19

5.6

3.8

24.87

24.85

mmol/l

0.13

1537

8022

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3054

18647

1.58

112.11

3.4

2.9

219.11

200.80

ng/l

1.03

2803

16970

(3023419) Bacteria identified in Sputum by Culture

789

3102

2.41

110.56

2.9

2.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1914

10427

1.76

108.94

4.7

3.3

25.25

25.31

mmol/l

0.30

1852

10120

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3352

21091

1.54

107.45

3.2

2.4

36.10

45.88

u/l

1.44

2858

18038

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1164

5424

2.04

107.29

3.7

3.0

24.96

24.72

mmol/l

1.01

1135

5301

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1607

8364

1.83

106.54

2.1

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

827

3389

2.31

105.45

1.8

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

827

3389

2.31

105.45

1.8

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1050

4750

2.10

104.79

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1050

4750

2.10

104.79

1.5

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1059

4817

2.09

104.16

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

991

4401

2.13

103.77

3.2

2.6

32.69

33.86

umol/l

0.88

884

3968

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1676

8914

1.80

103.40

5.4

4.9

1.74

1.65

2.26

1581

8356

(3048689) Calprotectin [Mass/mass] in Stool

4212

27990

1.47

103.27

2.5

2.3

145.96

133.72

ug/g

1.25

3380

21955

(1616796) Gas panel - Central venous blood

1065

4873

2.07

103.10

4.7

3.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2651

16036

1.59

100.66

1.5

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1642

8748

1.79

100.66

5.5

4.9

0.90

0.89

0.08

1548

8202

(3020891) Body temperature

1618

8608

1.79

99.64

5.7

4.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

692

2706

2.41

98.10

1.6

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1760

9650

1.74

97.63

5.1

3.9

49.53

48.05

1.66

1740

9547

(3052851) Hemolysis interference index of Serum or Plasma

1353

6859

1.88

97.36

3.6

3.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

941

4198

2.12

97.34

1.3

1.2

89.23

154.16

titre

0.91

(46235355) HIV 1 and 2 tests - Meaningful Use set

5431

38155

1.40

97.32

2.0

1.8

—

(3011412) CD3 cells [#/volume] in Blood

566

2027

2.63

96.53

2.5

2.4

1.18

1.21

e9/l

0.28

511

1804

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

761

3130

2.30

96.17

1.6

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1695

9244

1.75

95.77

2.3

1.9

39.64

39.41

u/l

0.17

1484

8178

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

430

1336

3.03

95.59

1.6

1.5

7.37

6.92

u/l

0.21

358

1065

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

707

2826

2.36

95.43

1.8

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

9240

70620

1.32

94.86

3.7

3.2

6.80

7.47

mmol/l

40.72

7872

59372

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

487

1629

2.81

94.78

1.3

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

819

3498

2.21

94.55

3.4

3.3

1.37

1.52

0.64

730

3096

(40767503) Oxygen content in Capillary blood by calculation

1005

4651

2.05

94.27

3.2

2.4

15.73

16.41

5.67

565

2356

(3018405) Lactate [Moles/volume] in Arterial blood

1442

7537

1.82

94.06

4.5

4.1

1.32

1.39

mmol/l

1.84

1411

7414

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

610

2318

2.48

92.03

1.9

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

27453

244161

1.53

91.62

15.6

10.1

25.47

26.19

u/l

5.33

26660

235314

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

418

1310

3.00

91.55

1.3

1.2

97.42

85.59

u/l

1.14

371

1129

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4626

32008

1.41

89.75

1.8

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

942

4354

2.05

88.63

1.7

1.4

—

(3047181) Lactate [Moles/volume] in Blood

1324

6870

1.83

88.35

6.0

5.6

1.27

1.31

mmol/l

0.69

1178

6073

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

933

4319

2.04

87.41

1.7

1.4

20.81

21.47

u/ml

0.05

(3010421) pH of Blood

1160

5804

1.90

86.78

5.5

3.7

7.42

0.14

1077

5284

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

403

1279

2.96

86.34

1.3

1.2

27.77

22.43

u/l

1.25

351

1082

(3008757) Leukocyte morphology finding [Identifier] in Blood

596

2310

2.43

86.16

3.8

3.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

539

1994

2.54

86.05

1.5

1.4

134185.22

122613.74

e6/l

0.14

364

1376

(3028626) Oxygen [Partial pressure] in Capillary blood

1059

5170

1.94

85.29

3.9

3.3

8.24

8.35

kpa

1.36

1039

5035

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

436

1460

2.81

84.72

1.7

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

24609

215260

1.35

83.86

21.7

12.7

80.24

81.16

ml/min/173m2

7.88

21215

176950

(3035947) Staphylolysin Ab [Units/volume] in Serum

334

970

3.23

83.25

1.2

1.1

3.57

3.80

iu/ml

0.18

(3021901) Oxygen saturation in Capillary blood

860

3937

2.06

83.02

3.2

2.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

769

3379

2.15

82.66

1.7

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1124

5670

1.88

81.95

1.3

7.79

7.75

u/ml

0.01

205

905

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

689

2910

2.23

81.72

1.6

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

958

4608

1.97

80.54

1.3

1.2

4.25

12.49

u/ml

0.84

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1106

5587

1.88

80.27

1.3

5.81

6.27

u/ml

0.07

135

583

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1625

9186

1.68

80.25

1.1

1.36

9.81

u/ml

1.34

128

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1193

6174

1.83

80.18

1.3

1.2

26.96

39.93

u/ml

1.23

366

(3042733) HLA Ab [Presence] in Serum

263

672

3.67

79.92

4.6

4.8

—

(3025941) Bacteria identified in Stool by Culture

2129

12892

1.58

79.68

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

2490

15626

1.53

79.42

3.5

2.7

4.95

4.97

e9/l

0.02

1844

12557

(1175426) CD3 cells/100 lymphocytes in Blood

453

1607

2.65

78.78

2.2

2.1

73.79

72.21

1.37

427

1549

(3024980) IgG subclass 4 [Mass/volume] in Serum

783

3537

2.09

78.32

1.6

0.70

0.77

g/l

0.73

576

2689

(3027315) Oxygen [Partial pressure] in Blood

1024

5086

1.91

78.27

5.7

3.7

8.51

8.65

kpa

1.88

1009

4953

(3012501) Base excess in Blood by calculation

1018

5051

1.91

78.06

5.7

3.7

2.68

2.56

mmol/l

0.66

737

3403

(3013290) Carbon dioxide [Partial pressure] in Blood

1018

5053

1.91

77.96

5.7

3.7

5.02

5.01

kpa

0.29

1003

4921

(3000012) Reticulocyte production index

681

2922

2.20

77.71

2.4

2.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

445

1577

2.65

77.55

2.1

14.95

15.13

0.12

427

1541

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

949

4614

1.95

77.31

1.6

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

910

4366

1.97

77.05

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

849

3978

2.02

76.88

1.7

1.4

114.63

115.16

u/ml

0.03

186

881

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1138

5882

1.83

76.76

2.3

2.0

11.48

11.05

mg/l

0.90

1041

5459

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

428

1495

2.69

76.74

2.2

2.1

—

(3008295) Osmolality of Serum or Plasma

536

2093

2.41

76.24

1.5

1.4

275.74

279.49

mosm/kgh2o

2.92

412

1623

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1004

5021

1.89

75.13

2.5

2.2

124.12

129.93

g/l

9.78

766

3619

(21494815) CD4 cells/100 lymphocytes in Specimen

481

1801

2.51

74.91

2.3

2.2

40.10

38.34

1.55

470

1770

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

449

1632

2.59

74.37

2.4

1.8

3.90

3.85

mg/l

0.07

430

1549

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1224

6541

1.77

73.87

3.8

2.5

3.68

3.57

g/l

1.55

1166

6215

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

942

4644

1.92

73.62

1.3

1.2

6.16

5.29

u/ml

0.11

353

(3028271) Lactate [Moles/volume] in Capillary blood

761

3487

2.06

73.26

2.3

1.8

1.60

1.74

mmol/l

4.08

748

3405

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

857

4109

1.97

72.69

1.4

1.3

276.25

270.74

u/ml

0.20

572

2583

(3039000) Anion gap in Blood

956

4756

1.90

72.68

6.7

6.6

11.21

11.19

mmol/l

0.09

869

4278

(3018572) Chloride [Moles/volume] in Blood

956

4757

1.90

72.63

6.7

6.6

104.23

105.18

mmol/l

6.45

869

4279

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

744

3397

2.07

72.31

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1248

6759

1.75

71.88

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

562

2302

2.30

71.72

1.8

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

562

2302

2.30

71.72

1.8

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4056

28400

1.38

71.71

9.9

6.8

—

(3036603) Volume of Urine

399

1396

2.68

71.34

1.6

1.5

1949.97

1920.62

0.27

391

1357

(3005322) IgE [Units/volume] in Serum or Plasma

2231

13992

1.52

71.03

1.4

1.3

276.84

232.39

u/ml

0.45

2078

12914

(4062490) Immunoglobulin typing, IgG

546

2222

2.31

70.75

1.5

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

546

2222

2.31

70.75

1.5

1.4

2.68

2.94

g/l

2.46

375

1567

(3024139) IgG subclass 3 [Mass/volume] in Serum

545

2222

2.31

70.32

1.5

1.4

0.37

0.41

g/l

2.11

376

1565

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

509

2016

2.37

70.17

1.7

1.5

28.37

30.87

0.91

333

1234

(3027135) IgG subclass 1 [Mass/volume] in Serum

545

2225

2.30

70.10

1.5

1.4

6.40

6.85

g/l

1.55

377

1562

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1259

6893

1.73

69.76

3.3

2.3

92.92

92.27

0.44

1203

6584

(3035637) Corticotropin [Mass/volume] in Plasma

623

2704

2.17

69.09

1.6

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

7832

60522

1.28

68.66

4.8

3.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2744

18069

1.46

68.50

3.1

2.6

61.32

65.98

ml/min/173m2

7.30

1225

7098

(3044889) 12 lead EKG panel

18673

159109

1.24

68.27

4.5

3.7

—

(3016038) Potassium [Moles/volume] in Urine

392

1399

2.63

67.41

1.3

1.2

32.03

34.77

mmol/l

1.48

318

1202

(3043409) Potassium [Moles/volume] in Arterial blood

1200

6551

1.74

67.15

4.8

4.3

3.86

3.87

mmol/l

0.14

1189

6501

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

391

1400

2.62

66.80

1.5

1.4

—

(3042631) Mycobacterium sp identified in Specimen

647

2892

2.11

66.54

2.8

2.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

17112

144632

1.24

66.45

3.2

2.9

—

(3024471) HLA-A [Type]

243

673

3.38

65.45

1.0

—

(3024928) Oxygen saturation in Venous blood

896

4516

1.87

65.41

5.3

3.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

23783

208811

1.29

65.27

6.6

5.6

40.39

39.67

mmol/mol

21.26

21936

192859

(3024522) Salmonella sp identified in Specimen by Organism specific culture

637

2856

2.10

64.99

1.5

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

332

1111

2.80

64.69

1.2

1.1

32.72

23.76

u/l

1.18

302

1000

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

635

2850

2.10

64.61

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

647

2928

2.08

64.41

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

630

2825

2.10

64.26

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

382

1379

2.60

64.22

1.5

1.4

—

(3014271) Vancomycin [Susceptibility]

324

1076

2.82

64.04

3.4

2.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

331

1112

2.79

64.03

1.2

1.1

94.01

83.59

u/l

0.82

305

1002

(3005988) Vibrio sp identified in Specimen by Organism specific culture

630

2830

2.10

63.96

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

629

2827

2.09

63.77

1.5

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

605

2682

2.12

63.58

2.4

2.1

32.60

32.53

0.16

599

2660

(3036489) Thrombin time

1441

8383

1.63

63.36

2.9

2.0

21.62

21.52

0.25

1245

7317

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2240

14399

1.48

63.02

3.2

3.3

4.39

4.47

pmol/l

3.03

1927

12778

(3024932) HLA-DR beta [Type]

237

664

3.34

62.71

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2293

14825

1.48

62.66

2.4

2.2

11.90

12.38

nmol/l

1.89

2001

13368

(3047189) Immunofixation for 24 hour Urine

280

875

3.00

61.78

2.1

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

421

1627

2.43

61.33

1.8

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

527

2244

2.21

61.32

1.8

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

243

703

3.24

61.08

2.1

1.7

55812.09

23724.68

u/ml

0.41

(3034770) Mitochondria Ab [Titer] in Serum

1115

6128

1.72

60.85

1.3

1.2

945.41

994.22

titre

0.09

185

(3018133) Calcium [Moles/volume] in Urine

156

336

4.34

59.97

2.6

2.0

2.66

2.51

mmol/l

0.38

144

300

(3010503) CD19 cells [#/volume] in Blood

350

1252

2.62

59.96

2.6

0.19

0.37

e9/l

1.01

340

1212

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1142

6351

1.70

59.68

3.8

2.4

199.89

188.39

3.75

1072

5998

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

389

1476

2.47

58.98

2.7

2.6

512.48

538.11

e6/l

0.31

325

1226

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

477

1981

2.26

58.98

3.3

2.7

—

(4200892) Spirometry reversibility

2471

16401

1.44

58.69

1.5

1.4

—

(40768804) Tissue Pathology biopsy report

11427

93405

1.22

58.04

2.2

2.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

1111

6199

1.69

57.34

1.3

1.2

113.92

127.50

titre

0.24

559

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1835

11551

1.51

57.01

3.5

2.6

0.27

0.29

e6/l

0.18

1790

11223

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

376

1427

2.47

57.00

2.8

2.6

0.23

e9/l

0.14

326

1223

(3009214) Lutropin [Units/volume] in Serum or Plasma

1069

5919

1.71

56.76

1.5

1.4

10.61

10.44

u/l

0.13

859

4804

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

485

2063

2.21

56.61

1.8

1.7

—

(3012565) Volume of 24 hour Urine

302

1034

2.74

56.41

2.5

2.1

1875.81

1978.04

0.91

283

904

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

265

848

2.93

56.11

3.2

2.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

28227

255290

1.47

55.24

35.8

20.0

39.10

40.26

70.98

26415

238994

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3705

26552

1.34

55.18

1.9

1.7

1.56

1.44

12.13

3173

23343

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

282

948

2.79

54.56

1.7

1.6

4.63

5.69

nmol/l

0.16

243

786

(3007461) Platelets [#/volume] in Blood

28238

255483

1.47

54.32

35.6

19.9

257.26

252.43

e9/l

27.15

27729

248445

(3010813) Leukocytes [#/volume] in Blood

28256

255688

1.47

54.19

35.6

19.9

6.96

6.69

e9/l

46.46

27689

247837

(3035941) MCH [Entitic mass]

28246

255632

1.47

53.54

35.4

19.8

30.31

30.26

4.10

27962

251764

(3024731) MCV [Entitic volume]

28246

255661

1.46

53.18

35.4

19.8

91.46

90.90

76.10

27960

251789

(3026361) Erythrocytes [#/volume] in Blood

28247

255684

1.46

53.03

35.6

19.9

4.35

4.49

e12/l

307.65

27680

247838

(3017354) Segmented neutrophils/100 leukocytes in Blood

494

2181

2.13

52.53

3.3

58.95

56.46

1.75

429

1820

(3000963) Hemoglobin [Mass/volume] in Blood

28246

255756

1.46

52.01

35.8

20.0

130.92

135.26

g/l

307.65

27959

251928

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1083

6172

1.66

51.54

1.1

9.67

6.45

u/ml

0.66

774

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1873

12093

1.47

51.20

2.5

2.4

—

(3022145) Colonoscopy Study observation

3545

25537

1.33

50.63

1.4

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1676

10612

1.50

50.47

1.1

269.84

217.71

titre

0.33

272

(3000093) Morphology [Interpretation] in Blood Narrative

468

2058

2.14

50.29

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

522

2400

2.04

49.86

1.2

1.1

0.86

2.26

iu/ml

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

849

4590

1.74

49.10

1.3

1.2

42.94

45.01

u/ml

0.14

101

446

(3012516) Albumin [Mass/volume] in Urine

8247

66044

1.22

48.93

3.8

3.2

855.28

387.66

mg/l

8.79

5456

41164

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

142

333

3.98

48.89

5.4

5.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1139

6681

1.61

48.28

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

288

1048

2.57

47.77

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

288

1048

2.57

47.77

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

302

1132

2.50

47.10

1.8

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

459

2056

2.10

47.04

3.8

3.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

330

1290

2.40

47.00

1.7

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

303

1141

2.49

46.80

1.8

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

262

924

2.65

46.30

1.9

2.1

102.54

137.40

umol/l

1.45

147

477

(40768446) Kidney Pathology biopsy report

239

809

2.77

45.73

2.0

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3277

23678

1.32

45.48

3.6

4.0

17.32

24.20

ug/l

1.06

2703

19068

(3004616) Nuclear Ab [Presence] in Serum

556

2702

1.93

45.40

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

370

1545

2.25

45.27

2.7

2.6

682.90

696.43

e6/l

0.12

353

1489

(3023420) DNA double strand Ab [Units/volume] in Serum

500

2365

1.99

44.17

1.8

1.5

41.93

29.10

iu/ml

0.63

106

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

413

1829

2.12

43.64

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

413

1829

2.12

43.64

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

413

1829

2.12

43.64

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1243

7627

1.54

43.31

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

481

2263

2.00

43.15

2.5

2.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3761

27877

1.29

43.08

4.6

4.5

33.32

32.52

4.13

2603

19135

(3020682) Albumin/Creatinine [Ratio] in Urine

8563

69507

1.21

42.97

4.3

3.8

15.87

8.35

mg/mmol

19.22

5538

42985

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

463

2156

2.02

42.76

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

121

279

4.05

42.68

13.0

10.0

5.34

5.20

mmol/l

0.13

121

279

(21494814) CD8 cells/100 lymphocytes in Specimen

231

800

2.70

42.35

1.9

2.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

261

961

2.54

42.32

1.2

1.1

—

(3016228) CD19 cells/100 cells in Blood

235

822

2.68

42.25

1.9

2.1

7.93

8.63

0.36

230

797

(3034891) Synovial lining cells/100 cells in Synovial fluid

275

1041

2.47

42.06

1.6

1.5

3.00

3.91

0.67

229

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

337

1398

2.26

41.92

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

561

2812

1.87

41.73

2.5

2.0

27.25

26.44

mg/l

0.10

131

751

(3036670) Protein [Mass/volume] in Synovial fluid

196

630

2.91

41.32

1.4

1.2

40.55

39.13

g/l

0.71

109

330

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

472

2256

1.96

40.51

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2228

15474

1.37

39.99

2.4

24.97

23.79

au/ml

0.16

143

1169

(3045424) Erythrocytes [Presence] in Urine

699

3798

1.73

39.75

1.6

1.5

—

(3045142) Bone marrow Pathology biopsy report

482

2338

1.93

39.63

1.4

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

938

5507

1.60

39.59

1.5

1.3

593.28

533.27

mg/l

0.69

885

5244

(3022229) Phosphate [Moles/volume] in Urine

114

5.89

39.35

3.3

1.9

19.00

18.59

mmol/l

0.06

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

845

4843

1.64

39.32

1.4

1.3

3.82

3.75

mmol/l

0.80

794

4546

(3024891) Influenza virus A+B Ag [Presence] in Specimen

977

5804

1.59

39.25

1.3

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

24710

220952

1.23

39.20

4.9

4.5

5.98

5.92

mmol/l

5.97

22406

201734

(3014765) Yersinia sp identified in Stool by Organism specific culture

1094

6675

1.55

39.09

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1095

6688

1.54

38.94

1.3

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

195

648

2.81

38.72

2.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1083

6611

1.55

38.61

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

387

1754

2.07

38.53

1.3

1.2

46.13

54.06

u/ml

0.15

(3002385) Erythrocyte distribution width [Ratio]

22430

198777

1.20

38.50

28.4

16.0

15.30

14.99

6.55

22191

195119

(4035726) Immunohistochemistry procedure

2798

20218

1.32

38.43

1.5

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2046

14114

1.38

38.26

1.3

60.68

52.31

au/ml

0.68

721

(3039162) Centromere protein B Ab [Units/volume] in Serum

549

2815

1.83

38.03

1.3

1.2

62.20

51.66

u/ml

0.50

180

(3037692) Legionella sp identified in Specimen by Organism specific culture

205

709

2.70

37.74

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

609

3232

1.77

37.63

1.3

1.2

4.26

3.72

u/ml

0.53

261

1470

(3027456) Digoxin [Moles/volume] in Serum or Plasma

767

4341

1.66

37.50

3.5

3.1

0.83

0.80

nmol/l

0.79

595

3355

(3017569) Oxygen content in Arterial blood

242

915

2.47

37.18

2.4

2.0

—

(3032057) Clostridioides difficile [Presence] in Stool

154

459

3.14

37.07

2.1

1.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

393

1825

2.02

36.65

1.3

1.2

185.58

181.21

titre

0.04

313

(3008898) HLA-B27 [Presence]

1157

7245

1.51

36.63

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

392

1820

2.02

36.58

1.3

1.2

89.23

176.82

titre

1.23

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

116

292

3.71

36.30

3.4

2.9

—

(21494755) Public health laboratory ask at order entry panel

1676

21251

0.72

36.12

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

374

1716

2.04

36.06

1.2

40.26

46.84

u/ml

0.23

141

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

373

1710

2.04

36.04

1.2

72.00

73.91

u/ml

0.04

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

287

1187

2.26

36.04

2.4

2.8

41.49

38.95

1.15

155

675

(3045414) Leukocytes [Presence] in Urine

1541

10242

1.42

35.83

2.1

1.8

—

(3019977) pH of Arterial blood

279

1148

2.27

35.47

2.9

2.4

7.42

0.11

112

394

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

271

1103

2.30

35.35

1.8

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

271

1105

2.30

35.20

1.8

1.9

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

219

812

2.52

35.09

2.4

2.1

28.87

29.23

0.14

201

777

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

619

3368

1.73

35.07

1.3

36.36

33.73

u/l

0.23

550

2906

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

358

1635

2.05

34.97

1.3

1.2

8.61

9.98

u/ml

0.09

113

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

615

3347

1.73

34.82

1.3

1.2

3.03

4.03

u/ml

0.93

210

1154

(3011985) Renin [Units/volume] in Plasma

571

3045

1.76

34.73

1.7

1.5

62.21

58.51

mu/l

0.20

498

2713

(3006245) CD3-CD19+ cells/100 cells in Blood

221

829

2.49

34.57

2.5

2.3

9.17

10.90

1.50

198

779

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

312

1362

2.15

34.33

1.3

1.2

—

(1761868) Lipid panel - Serum or Plasma

7612

80330

0.84

34.17

3.0

2.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1568

19914

0.72

34.04

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

517

2704

1.79

33.61

1.2

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

145

4.83

33.07

4.5

4.2

2.30

2.15

mg/l

0.26

116

(21494434) Karyotype in Bone marrow

379

1807

1.97

32.86

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

555

2984

1.75

32.83

2.2

2.0

12.00

5.26

titre

0.58

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

235

931

2.36

32.66

2.5

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

221

853

2.42

32.54

1.9

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

221

853

2.42

32.54

1.9

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

213

812

2.45

32.23

1.4

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

639

3594

1.67

32.05

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

153

4.63

31.95

1.6

1.3

—

14.28

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

242

981

2.31

31.92

3.8

3.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

222

867

2.39

31.87

2.0

2.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

170

585

2.72

31.70

1.4

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

810

4855

1.57

31.35

1.6

1.4

18.48

34.61

e6/l

1.91

630

3757

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

810

4860

1.57

31.21

1.6

1.4

1362.77

2904.39

e6/l

0.70

666

3959

(3048879) Bone marrow aspiration report

170

590

2.69

31.19

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

342

1605

2.00

31.05

1.6

1.5

27.68

24.03

u/ml

0.54

332

(3016650) Hepatitis A virus Ab [Presence] in Serum

628

3556

1.66

30.71

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

246

1023

2.25

30.58

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

246

1023

2.25

30.58

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

772

4607

1.58

30.46

1.3

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

480

2535

1.78

30.25

21.9

7.2

7.65

7.39

mmol/l

0.35

408

2066

(3025577) Chromium [Mass/volume] in Blood

285

1265

2.11

30.12

2.2

2.0

2.70

2.39

ug/l

0.45

244

1046

(40761536) Microorganisms panel - Urine sediment

2611

19290

1.29

30.01

5.8

3.9

—

(3044290) Cell count panel - Cerebral spinal fluid

762

4553

1.57

29.91

1.5

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

513

2774

1.73

29.78

1.5

30.79

33.26

g/l

4.11

446

2494

(3026389) Candida sp identified in Specimen by Organism specific culture

599

3378

1.66

29.77

1.5

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

530

2899

1.72

29.53

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

501

2703

1.74

29.33

1.1

—

(3002619) Bacteria identified in Specimen by Culture

137

442

2.89

28.86

1.5

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

351

1707

1.93

28.78

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

355

1741

1.91

28.40

2.0

2.3

18.31

19.12

nmol/l

0.80

324

1656

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

351

1717

1.91

28.29

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

282

1278

2.06

28.24

2.9

2.2

100.90

97.19

0.92

265

1192

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

351

1719

1.91

28.20

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

349

1707

1.91

28.15

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

572

3236

1.66

28.11

1.3

2.09

1.48

nmol/l

0.16

554

3106

(3008536) Aspergillus sp Ab [Presence] in Serum

130

414

2.93

28.04

2.3

2.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

350

1716

1.91

28.03

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

348

1704

1.91

27.98

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

285

1306

2.04

27.71

2.1

1.9

4.40

3.64

ug/l

0.47

262

1191

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

278

1263

2.06

27.67

1.1

1.08

1.07

ratio

0.16

105

441

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

117

354

3.09

27.59

1.2

1.1

2.22

8.38

pmol/l

0.76

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

231

978

2.21

27.56

1.1

17.27

13.05

u/ml

0.16

(3013005) Retinol [Moles/volume] in Serum or Plasma

220

914

2.25

27.47

2.3

1.9

1.99

1.93

umol/l

0.37

208

852

(3051611) Lipemic interference index of Serum or Plasma

453

2423

1.75

27.37

4.2

3.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

278

1270

2.05

27.27

1.5

1.4

5.47

5.84

u/l

0.44

234

1075

(3044242) Glucose [Moles/volume] in Arterial blood

227

959

2.21

27.23

2.6

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

404

2093

1.81

27.21

1.4

1.5

—

(40768443) Skin Pathology biopsy report

1479

10231

1.36

27.02

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

355

1775

1.87

26.80

1.5

1.4

1.38

1.34

promille

0.15

273

1331

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

142

488

2.72

26.64

1.1

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

114

347

3.07

26.63

1.6

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

172

650

2.47

26.62

1.6

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

565

3245

1.63

26.20

1.3

0.24

0.22

nmol/l

0.10

200

(3018851) Theophylline [Moles/volume] in Serum or Plasma

171

4.04

26.19

1.9

1.7

53.55

45.64

umol/l

0.92

171

(3023199) Leukocytes [#/volume] in Pleural fluid

459

2499

1.72

26.07

1.5

2699.61

3432.31

e6/l

0.52

339

1787

(3049717) Cytology report of Urine Cyto stain

1179

7909

1.40

25.96

2.4

2.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

306

1473

1.94

25.92

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

196

799

2.29

25.64

1.1

—

(3022621) pH of Urine by Test strip

2065

15101

1.29

25.57

3.9

2.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

437

2365

1.73

25.37

1.8

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

306

1485

1.93

25.32

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1022

13264

0.71

25.08

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

162

613

2.47

25.04

2.7

2.2

390.00

409.10

e6/l

0.03

335

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

283

3.23

25.02

2.0

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

663

4000

1.56

25.00

1.5

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

287

1369

1.96

24.99

1.4

1.3

109.09

57.39

titre

0.43

119

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

502

2834

1.66

24.93

1.3

518.56

362.61

pmol/l

0.34

422

2486

(21491868) Cryoglobulin [Mass/volume] in Serum

186

751

2.31

24.89

1.3

1.2

1.16

0.30

g/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

188

765

2.30

24.72

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

414

2224

1.74

24.69

2.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

542

3129

1.62

24.64

1.1

122.80

118.37

2.30

493

2803

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

292

1408

1.94

24.64

1.4

1.3

300.00

465.89

titre

0.56

107

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

318

1578

1.89

24.62

1.3

1.39

1.64

u/ml

0.27

216

849

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

515

2946

1.64

24.30

1.4

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

207

887

2.18

24.05

2.4

1.8

27.62

29.32

umol/l

1.38

199

854

(3028433) Virus identified in Specimen by Culture

181

734

2.30

24.00

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

260

1227

1.98

23.38

1.3

204.19

346.43

u/l

2.60

247

1127

(3051651) Icteric interference index of Serum or Plasma

281

1367

1.92

23.14

4.7

3.6

—

(3045788) Cell count panel - Pleural fluid

360

1916

1.76

22.24

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

550

3268

1.58

22.22

1.1

—

(3024263) Appearance of Synovial fluid

242

1142

1.98

21.81

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

719

4551

1.48

21.69

2.9

3.4

446.69

940.67

u/ml

1.20

647

4154

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

229

1064

2.01

21.57

1.1

—

(3012441) Differential panel - Pleural fluid

390

2148

1.70

21.34

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

160

649

2.30

21.27

3.2

3.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

306

1576

1.82

21.14

1.9

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

314

1633

1.80

21.01

1.3

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

228

1069

1.99

20.95

1.9

1.5

20.08

25.52

umol/l

2.23

217

1010

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

143

556

2.40

20.93

1.7

153.73

136.53

au/ml

0.11

(3013727) Leukocytes other/100 leukocytes in Blood

166

690

2.25

20.85

4.0

3.4

54.71

52.50

0.64

161

666

(3009015) Lactate [Moles/volume] in Synovial fluid

224

3.29

20.84

1.4

1.2

5.64

6.47

mmol/l

0.48

107

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

847

5578

1.43

20.76

1.8

28.50

11.31

iu/l

0.51

264

2019

(3019420) Tryptase [Mass/volume] in Serum or Plasma

241

1167

1.93

20.20

1.9

1.4

12.50

7.74

ug/l

1.43

220

1065

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

290

1493

1.82

20.09

1.6

1.4

12.85

12.70

u/l

0.14

280

1440

(40768806) Pleura Pathology biopsy report

386

2158

1.67

20.01

1.6

1.5

—

(3011648) Oxygen content in Venous blood

314

1658

1.77

19.99

4.8

2.4

10.97

11.01

0.07

314

1658

(3028707) Methadone [Presence] in Urine by Screen method

568

3484

1.53

19.97

3.5

2.6

—

(3002256) Pathology report gross observation

3726

29783

1.19

19.87

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

166

705

2.20

19.82

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

748

4860

1.44

19.75

4.3

3.1

1.53

1.59

mmol/l

1.07

735

4762

(3028308) Erythrocytes [#/volume] in Pleural fluid

402

2281

1.65

19.69

1.5

62455.07

48522.24

e6/l

0.33

242

1334

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

345

1881

1.72

19.64

1.3

312.91

503.61

u/l

2.90

323

1781

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

332

2.78

19.59

1.3

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

156

651

2.24

19.45

1.4

54.54

55.35

0.10

133

553

(3036180) Methadone [Presence] in Urine

207

970

1.99

19.10

3.5

2.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

134

535

2.34

18.55

1.6

1.3

39.03

37.85

0.13

349

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

322

2.75

18.46

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

173

772

2.09

18.26

1.4

15.26

15.24

pmol/l

0.02

140

645

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

243

1222

1.86

18.21

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

160

3.56

18.19

2.4

2.6

—

(3034988) Calcium [Moles/volume] in Capillary blood

110

405

2.53

18.16

4.3

2.0

1.18

mmol/l

0.32

104

388

(3006922) Hepatitis E virus Ab [Presence] in Serum

289

1538

1.76

17.97

1.1

—

(3004451) EKG impression Narrative

215

1044

1.92

17.94

1.3

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.46

17.81

9.8

11.9

201.93

292.32

e6/l

0.30

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

164

3.47

17.55

1.4

1.2

15.60

15.14

nmol/l

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

158

692

2.13

17.53

2.1

2.0

8.30

9.34

mg/l

1.46

131

562

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

270

1422

1.78

17.42

1.1

—

(4034850) Laboratory test

1045

7334

1.34

17.41

13.2

9.5

—

(3003694) ABO and Rh group [Type] in Blood

7390

62651

1.13

17.35

1.5

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

198

3.20

17.27

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

179

827

2.02

17.24

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

206

1000

1.92

17.22

1.3

1.2

140.33

160.56

mmol/24h

3.14

206

1000

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

268

1414

1.77

17.19

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

862

5886

1.37

17.15

1.8

1.7

42.22

40.81

nmol/l

0.93

830

5736

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

398

2335

1.60

17.10

1.2

1.1

94.46

95.77

0.43

373

2174

(3022493) Free Hemoglobin [Mass/volume] in Plasma

196

938

1.95

17.09

3.8

5.2

67.78

1839.80

mg/l

2.33

146

671

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

326

1825

1.67

16.90

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

343

2.61

16.88

1.4

76.97

356.98

ng/l

0.58

215

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

421

2515

1.57

16.75

3.5

3.2

7.12

8.64

nmol/l

0.26

399

2441

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

486

2998

1.52

16.72

1.1

1.56

1.51

g/l

1.86

434

2705

(3041354) Potassium [Moles/volume] in Venous blood

455

2769

1.54

16.67

2.9

2.3

4.10

4.05

mmol/l

1.34

450

2750

(40757373) Influenza virus identified in Isolate

111

428

2.42

16.66

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

253

1326

1.78

16.62

2.9

3.2

23.37

28.09

mu/l

1.37

240

1241

(3035285) Chloride [Moles/volume] in Venous blood

454

2767

1.54

16.53

2.9

2.3

105.05

105.55

mmol/l

1.33

449

2748

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

310

2.68

16.47

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

282

1533

1.72

16.32

1.5

1.4

13.48

12.26

umol/l

1.84

268

1456

(3052592) Norovirus Ag [Presence] in Stool

110

427

2.40

16.28

1.4

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

306

1703

1.68

16.25

1.2

1.3

2.02

2.12

mmol/l

0.87

280

1579

(3036782) Glucose [Moles/volume] in Pleural fluid

338

1932

1.64

16.18

1.4

1.3

6.66

6.34

mmol/l

1.19

310

1777

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

485

3016

1.51

16.08

2.6

2.8

1793.00

629.66

u/ml

0.40

478

2980

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

252

2.85

16.03

1.3

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

114

454

2.34

15.95

1.1

—

(3035880) pH of Pleural fluid

219

1113

1.84

15.94

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

629

4123

1.43

15.92

2.0

1.9

185.47

196.64

pmol/l

2.14

600

3910

(3008116) Ketones [Moles/volume] in Urine by Test strip

110

433

2.37

15.80

1.5

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

100

378

2.47

15.69

4.2

1.9

1.19

mmol/l

0.02

364

(40768441) Liver Pathology biopsy report

289

1604

1.68

15.53

1.7

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

155

708

2.04

15.46

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

183

3.16

15.44

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

687

4605

1.40

15.33

4.5

3.2

7.46

7.60

mmol/l

0.52

675

4523

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

223

2.93

15.31

2.1

2.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4869

40475

1.14

15.24

1.6

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

121

505

2.24

15.20

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1122

8118

1.30

15.07

2.9

3.4

414.79

1473.28

u/ml

1.98

945

6915

(3033705) Calcium.ionized [Moles/volume] in Venous blood

441

2727

1.51

15.06

3.0

2.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

268

1472

1.70

14.99

1.3

12.17

13.71

u/l

0.88

235

1359

(3003129) Base excess in Capillary blood by calculation

125

533

2.19

14.92

2.0

1.7

0.90

0.66

mmol/l

0.24

118

500

(3036071) Salmonella sp Ab [Titer] in Serum

143

643

2.08

14.90

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

201

1018

1.84

14.84

10.6

10.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

503

3205

1.47

14.83

4.6

5.1

349.30

367.36

umol/l

2.00

430

2765

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

227

1199

1.77

14.60

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

225

1188

1.77

14.49

2.4

2.1

16.16

31.51

umol/l

1.90

121

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

850

5952

1.34

14.44

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

655

4406

1.39

14.35

4.2

1.7

0.86

0.83

nmol/l

0.39

531

3692

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

115

482

2.23

14.33

1.3

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

111

459

2.26

14.29

1.4

1.3

66.90

80.48

mu/l

0.28

335

(3016018) Differential panel - Cerebral spinal fluid

395

2418

1.53

14.17

1.6

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

292

1673

1.63

13.93

1.1

272.67

262.60

mg/l

0.24

243

1483

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

301

1740

1.62

13.86

1.1

1.2

38.54

42.20

mg/l

0.81

241

1467

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

306

2.53

13.79

1.2

1.4

8.23

228407.34

nmol/l

1.67

250

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

621

4170

1.39

13.77

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1507

11428

1.24

13.71

1.3

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

633

2.03

13.68

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

163

3.15

13.66

1.6

1.75

1.91

mg/l

0.07

110

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

898

6392

1.32

13.64

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

139

641

2.02

13.58

3.0

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

139

641

2.02

13.58

3.0

2.4

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

267

1509

1.65

13.47

3.3

159.55

137.14

nmol/l

0.33

260

1491

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.84

13.43

3.9

3.4

—

(3000492) Spirometry study

2766

22253

1.17

13.39

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

140

651

2.01

13.38

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

394

2445

1.51

13.30

4.5

3.7

55.16

50.72

u/ml

0.14

382

2416

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

279

1600

1.63

13.29

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

409

2561

1.49

13.22

1.9

1.7

3244.44

2688.60

titre

—

107

(3032352) Blasts [#/volume] in Cerebral spinal fluid

201

2.88

13.21

3.0

2.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

167

3.07

13.13

5.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

758

5298

1.34

13.08

2.5

2.2

157.24

104.96

ug/min

2.02

447

3091

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

121

3.47

13.03

4.8

4.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1141

8442

1.27

12.88

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

328

2.42

12.85

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

132

611

2.02

12.80

1.6

9.57

9.01

ug/l

0.69

132

611

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

120

537

2.09

12.74

1.2

331.68

301.91

pmol/l

0.19

384

(42529582) MDA5 Ab [Presence] in Serum by Line blot

120

538

2.08

12.68

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

120

538

2.08

12.68

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

120

538

2.08

12.68

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

120

538

2.08

12.68

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

142

3.22

12.65

3.3

2.8

—

(3009871) Measles virus Ab [Titer] in Serum

151

736

1.92

12.63

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

222

1220

1.70

12.49

1.3

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

195

1034

1.76

12.46

2.2

2.0

156.16

143.91

1.14

179

967

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

158

786

1.88

12.43

3.1

3.3

8.68

7.90

mg/l

0.71

126

622

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

159

3.05

12.29

1.6

1.67

2.48

mg/l

0.54

120

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

159

3.05

12.29

1.6

2.25

2.75

mg/l

0.26

107

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

159

3.05

12.29

1.6

1.54

0.95

mg/l

0.49

109

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

159

3.05

12.29

1.6

1.50

2.03

mg/l

0.29

108

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

159

3.05

12.29

1.6

1.60

1.94

mg/l

0.18

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

159

3.05

12.29

1.6

2.26

4.29

mg/l

1.79

106

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

159

3.05

12.29

1.6

0.86

1.05

mg/l

0.18

103

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

159

3.05

12.29

1.6

2.57

2.86

mg/l

0.10

114

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

159

3.05

12.29

1.6

1.59

1.65

mg/l

0.05

116

(3026692) Albumin [Mass/volume] in Peritoneal fluid

116

521

2.08

12.22

1.8

1.4

11.75

13.78

g/l

1.64

403

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

181

947

1.78

12.12

1.0

1.1

98.69

97.05

0.30

146

742

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

310

2.41

12.02

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

24692

225157

1.12

11.82

4.7

4.4

4.61

4.70

mmol/l

32.59

22684

208832

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

257

2.54

11.80

2.1

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

980

7197

1.28

11.79

1.8

1.7

310.88

315.63

mu/l

0.13

909

6519

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

147

729

1.88

11.71

1.2

110.59

107.32

0.42

133

661

(3043410) Blood group antigens tested for on Red Blood Cells

126

594

1.98

11.65

2.2

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

23713

215798

1.11

11.65

4.2

3.9

1.32

1.30

mmol/l

3.58

21523

197582

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

146

724

1.88

11.63

2.5

2.8

158.77

157.30

au/ml

0.01

(3011288) Drugs identified in Urine by Screen method

765

5452

1.31

11.58

3.4

2.8

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

117

539

2.03

11.55

1.5

1.2

115.94

130.84

nmol/l

0.43

389

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

691

8446

0.76

11.53

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.03

11.49

2.9

3.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

983

7246

1.27

11.49

2.4

2.3

4394.07

5700.66

u/l

0.77

340

2809

(3014051) Protein [Presence] in Urine by Test strip

833

6016

1.30

11.44

3.2

2.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

472

3126

1.41

11.43

1.5

1.3

29.83

29.24

u/l

0.13

388

2554

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

25121

229403

1.12

11.32

5.2

4.9

2.67

2.78

mmol/l

61.53

22979

211733

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

311

1907

1.52

11.19

1.5

1.3

1.50

1.41

nmol/l

0.65

278

1714

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

792

5701

1.30

11.16

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

179

2.81

11.11

1.3

1.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

5.39

11.11

10.2

8.8

35.27

48.06

1.06

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

518

3509

1.38

11.00

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

255

2.49

11.00

9.9

8.6

0.42

0.41

umol/l

0.05

230

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

125

604

1.93

10.81

1.9

2.0

26.42

38.48

u/l

0.59

114

547

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

231

1335

1.62

10.78

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

468

3132

1.40

10.70

1.1

4.27

3.28

u/ml

0.31

141

1479

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

310

2.32

10.68

1.2

39.79

40.10

mg/l

0.02

262

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.76

10.57

9.5

8.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

185

1017

1.70

10.49

3.6

3.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

276

1676

1.54

10.43

1.0

1.1

298.41

289.89

mg/l

0.84

241

1497

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

139

704

1.84

10.43

1.1

92.83

88.93

0.50

308

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1527

11937

1.20

10.31

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.88

10.28

2.9

3.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.62

10.25

1.5

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

116

558

1.94

10.19

1.3

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

300

2.30

10.12

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

266

2.38

10.08

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

219

1271

1.61

10.08

2.1

1.8

2.48

2.51

u/field

0.02

157

893

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

204

1164

1.64

10.06

1.1

1.09

1.08

u/l

0.12

530

(3020393) Adenovirus Ag [Presence] in Stool

244

2.45

10.03

1.5

1.3

—

(40762814) Titanium [Mass/volume] in Blood

373

2.15

10.01

2.4

2.2

3.31

3.91

ug/l

0.66

130

(43055442) Apixaban [Mass/volume] in Serum or Plasma

296

2.30

9.99

1.7

1.5

110.17

114.65

ug/l

0.12

244

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

171

936

1.71

9.88

1.5

1.6

1697187.08

2157527.19

iu/ml

0.17

(3002331) Protein [Mass/volume] in Peritoneal fluid

101

469

2.01

9.83

1.5

1.4

22.11

30.46

g/l

1.75

358

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

303

1902

1.49

9.82

2.3

2.1

2.60

2.21

u/field

0.43

141

779

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

159

855

1.74

9.80

2.8

2.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

24459

223393

1.10

9.79

4.7

4.3

1.49

1.48

mmol/l

2.91

22354

206170

(3033799) Differential panel - Peritoneal fluid

131

665

1.84

9.79

2.1

1.8

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

253

2.40

9.76

1.4

1.3

62.69

202.93

u/l

0.59

183

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

217

1270

1.60

9.67

1.0

1.1

3.23

5.92

nmol/l

0.60

253

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1913

15337

1.17

9.66

1.2

131.03

144.25

iu/ml

0.73

694

5739

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

238

2.43

9.60

1.5

1.4

75.83

71.72

0.54

195

(3005570) Glucose [Moles/volume] in Urine

359

2340

1.43

9.59

2.2

1.9

—

0.88

—

(3019174) dRVVT (LA screen)

178

2.67

9.58

1.3

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

368

4807

0.71

9.57

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

189

1076

1.64

9.43

1.3

1.2

66.00

63.39

0.12

125

(3046861) Legionella sp Ag [Presence] in Urine

104

3.23

9.42

1.2

1.0

—

(3000330) Specific gravity of Urine by Test strip

1462

11495

1.19

9.30

4.7

3.5

—

(3006462) Nitrate [Presence] in Urine

191

1096

1.63

9.25

4.4

3.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

397

2652

1.40

9.25

2.1

1.9

26.01

22.99

ug/l

0.19

383

2587

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

150

2.80

9.23

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

296

2.24

9.14

1.5

1.2

1.43

1.54

mmol/l

0.06

192

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

145

776

1.74

9.12

1.2

0.31

0.30

g/l

0.54

114

635

(40763480) Human metapneumovirus Ag [Presence] in Specimen

102

3.20

9.05

1.5

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

202

1183

1.59

9.01

1.6

1.5

1.12

1.24

nmol/l

1.04

158

923

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

184

2.58

9.00

1.3

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

118

3.00

8.85

1.2

1.1

45.56

65.49

u/l

0.76

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

192

2.52

8.77

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

171

2.62

8.70

1.3

1.18

1.19

ml/s/173m2

0.02

115

(3023383) Lactate [Moles/volume] in Pleural fluid

122

630

1.81

8.69

1.4

1.3

3.12

3.45

mmol/l

0.52

113

579

(1001926) Buprenorphine [Presence] in Urine by Screen method

843

6316

1.25

8.68

3.0

2.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1602

12777

1.18

8.64

3.2

3.5

49.81

58.52

u/ml

0.74

1534

12329

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

134

714

1.75

8.59

1.2

113.49

111.59

0.35

120

641

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

137

736

1.74

8.54

1.4

61.45

63.42

0.24

103

620

(3041918) Cholesterol [Moles/volume] in Pleural fluid

379

2.04

8.52

1.4

1.2

1.59

1.72

mmol/l

0.40

229

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

469

1.93

8.48

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

135

724

1.74

8.47

1.1

90.88

89.53

0.18

312

(3047352) Trisomy 18 risk [Likelihood] in Fetus

267

3607

0.69

8.47

1.5

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

328

2157

1.42

8.41

1.4

1.3

—

(3012898) Urea [Moles/volume] in Urine

213

2.41

8.41

1.2

1.4

151.71

176.74

mmol/l

0.72

193

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

348

4484

0.72

8.40

1.5

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

276

3696

0.69

8.35

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

348

4479

0.72

8.34

1.4

—

(3023410) Appearance of Cerebral spinal fluid

341

2262

1.41

8.33

2.0

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

466

1.92

8.31

2.8

2.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

346

4453

0.72

8.29

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

192

2.48

8.29

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

352

2.07

8.28

3.1

2.6

37.37

56.01

mg/l

0.49

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

348

4472

0.72

8.27

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

142

781

1.70

8.16

2.6

1.9

1262.75

3013.35

e6/l

0.75

529

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

156

2.63

8.08

1.2

—

(3005033) Fetal Nuchal fold Thickness US

269

3594

0.69

8.05

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

860

6516

1.24

8.03

1.3

214.78

220.68

miu/ml

0.17

311

2976

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

558

4015

1.30

8.03

4.7

3.4

42.99

38.97

u/ml

0.19

545

3880

(40758292) HTLV I+II Ab panel - Serum

338

2.07

8.00

1.5

1.4

—

(4146454) Self-monitoring of blood glucose

362

2444

1.38

7.99

2.8

2.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.90

7.96

3.0

3.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.90

7.96

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.54

7.96

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

138

759

1.70

7.94

6.8

6.3

24.50

25.17

mmol/l

1.35

126

687

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

463

3252

1.33

7.93

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

117

619

1.76

7.74

1.4

2.86

2.69

0.07

531

(3020618) Glucose [Moles/volume] in Synovial fluid

3.46

7.63

1.1

1.0

5.76

5.33

mmol/l

0.20

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

289

2.13

7.61

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1005

11200

0.83

7.56

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

490

3495

1.31

7.55

1.1

14.70

11.18

au/ml

0.30

198

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

309

2.08

7.51

6.1

4.6

49.32

45.86

ug/min

0.21

239

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

496

1.84

7.51

1.5

1.4

24.94

22.64

0.29

418

(3047007) Chlamydophila sp Ab [Presence] in Serum

457

3232

1.32

7.49

1.2

—

(40768795) Lymph node Pathology biopsy report

337

2278

1.38

7.43

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

310

2069

1.40

7.37

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

511

3685

1.30

7.28

1.5

1.3

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

106

557

1.77

7.21

1.4

19.78

20.70

0.13

515

(3035320) C reactive protein [Mass/volume] in Body fluid

263

1715

1.43

7.15

3.3

2.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

499

1.81

7.09

1.3

1.2

111.16

108.24

0.38

478

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6858

60115

1.08

7.06

1.7

1.6

1.41

1.37

mmol/l

2.72

5843

50416

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

125

693

1.68

7.04

2.4

1.8

5067.03

10687.20

e6/l

0.99

371

(3011436) Histone Ab [Units/volume] in Serum

467

1.84

7.02

1.1

—

40.71

u/ml

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

256

2.15

7.00

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

331

2256

1.37

6.97

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

115

2.76

6.88

1.3

1.4

331.65

303.57

umol/24h

0.29

115

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

486

1.80

6.78

1.4

1.1

101.97

83.39

2.19

132

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

218

2.22

6.72

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

109

591

1.72

6.69

1.3

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3466

35188

0.91

6.65

3.0

2.9

0.74

0.76

ug/l

0.38

2262

22755

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

129

733

1.64

6.64

2.3

2.5

1.34

1.12

ug/l

0.57

120

695

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

194

1211

1.49

6.64

1.5

1.6

—

(3016750) Collection duration of Urine

201

1265

1.48

6.61

2.6

2.1

518.01

498.65

min

1.89

139

964

(3034426) Prothrombin time (PT)

131

749

1.63

6.59

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

361

2518

1.34

6.57

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

153

915

1.56

6.40

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

355

1.92

6.39

2.0

1.8

42.58

59.14

pmol/l

0.98

293

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

137

800

1.60

6.34

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

485

1.77

6.25

1.2

86.23

71.70

1.12

125

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

469

3418

1.28

6.23

1.1

62.63

3729.56

iu/ml

0.66

110

751

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

136

797

1.59

6.22

2.4

2.0

177.81

167.75

0.42

131

752

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

245

2.09

6.15

1.8

2.5

0.65

1.35

mmol/l

3.08

170

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.99

6.11

1.7

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

207

1334

1.45

6.07

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

150

2108

0.66

5.99

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

117

668

1.63

5.97

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

157

961

1.52

5.95

2.4

48.94

52.56

umol/l

0.67

134

822

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

405

1.82

5.91

2.1

1.9

15.49

16.56

umol/l

0.41

405

(3042517) Benzodiazepines panel - Urine

237

2.08

5.89

2.8

2.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

103

571

1.68

5.89

1.3

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

177

2.26

5.85

2.6

2.2

61.41

58.55

0.15

114

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4900

48733

0.92

5.85

4.2

4.1

21.69

21.92

0.44

2202

22934

(3016879) Cocaine [Presence] in Urine

964

7628

1.18

5.84

2.8

2.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

181

1146

1.47

5.84

1.6

1.3

3.61

4.71

umol/l

4.25

160

1054

(3023323) Follitropin [Units/volume] in Serum or Plasma

1201

9675

1.16

5.82

1.5

1.4

28.31

29.58

iu/l

0.63

1036

8287

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

109

616

1.65

5.80

1.4

1.6

—

390.56

iu/ml

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

518

1.71

5.78

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

281

1929

1.36

5.74

1.2

328.44

362.87

nmol/l

1.93

221

1616

(3035611) Eosinophils/100 leukocytes in Synovial fluid

144

2.39

5.71

1.5

1.8

1.08

0.55

0.45

111

(3044007) Cell count panel - Peritoneal fluid

109

620

1.64

5.66

2.2

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

339

4120

0.76

5.66

1.4

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

208

1362

1.43

5.64

1.1

—

(40768793) Breast Pathology biopsy report

710

5484

1.21

5.63

1.3

—

(3006969) Lambda light chains [Mass/volume] in Urine

3.57

5.57

1.1

1.0

0.19

0.02

g/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

175

1114

1.47

5.52

1.2

—

(3017509) Phencyclidine [Presence] in Urine

225

2.07

5.49

1.3

1.7

—

(44786800) Granulocytes/100 leukocytes in Body fluid

257

1.99

5.46

1.5

1.3

26.84

24.16

0.22

198

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

131

2.42

5.38

1.1

1.2

1.13

1.12

u/field

0.03

(3000764) Benzodiazepines [Presence] in Urine

1023

8194

1.17

5.37

2.7

2.0

—

(3001729) Color of Synovial fluid

172

2.22

5.37

1.4

1.7

—

(3028300) Cannabinoids [Presence] in Urine

1031

8265

1.17

5.36

2.8

2.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

491

5657

0.81

5.29

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

110

2.54

5.27

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2448

24989

0.90

5.24

1.6

1.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

463

1.71

5.23

7.0

5.9

64.75

69.73

0.81

359

(3027008) Opiates [Presence] in Urine

1027

8248

1.17

5.22

2.5

1.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

493

1.68

5.16

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

398

1.76

5.07

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1860

15573

1.12

5.07

1.2

—

(4212803) Bone marrow aspirate examination

195

2.10

5.05

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

159

2.23

5.03

1.6

1.1

45.57

45.74

mg/l

0.01

(3032773) Endomysium IgG Ab [Titer] in Serum

279

1957

1.33

5.01

1.1

—

73.33

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

395

1.75

4.92

1.3

1.4

86.80

193.43

titre

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

167

1081

1.44

4.88

4.9

5.6

41.87

4135.61

u/ml

0.68

196

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

116

698

1.55

4.84

1.3

1.2

27.80

21.34

0.32

107

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

384

1.75

4.81

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

385

1.74

4.77

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

385

1.74

4.77

1.3

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.58

4.72

1.3

1.07

1.25

u/field

0.46

(3007916) DNA double strand Ab [Titer] in Serum

278

1.88

4.72

1.7

1.2

122.50

189.59

titre

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

154

991

1.45

4.67

1.1

1590.16

1533.25

miu/ml

0.28

154

991

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

164

1068

1.43

4.66

1.1

5.36

8.46

u/ml

0.88

176

(3035933) Granulocytes/100 leukocytes in Blood

580

1.59

4.65

2.1

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

745

5891

1.18

4.64

5.9

4.2

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.39

4.62

1.3

1.6

150.55

418.92

nmol/l

1.46

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

142

902

1.47

4.61

1.1

146.69

603.66

ng/l

1.45

212

(40765096) Chromosome analysis panel by Banding

103

612

1.57

4.57

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

250

1755

1.33

4.51

2.6

2.2

730.08

667.72

1.44

171

1204

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

129

808

1.49

4.50

2.4

3.0

29.04

28.54

umol/l

0.19

617

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

153

991

1.44

4.50

3.1

1.9

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

149

2.19

4.48

1.5

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

528

1.61

4.47

1.7

1.2

16.27

16.97

umol/l

0.79

463

(3024316) Viscosity of Plasma

2.50

4.45

1.5

1.7

1.69

1.57

mpas

0.37

(3027944) Amphetamines [Presence] in Urine

1000

8121

1.15

4.44

2.7

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

218

1505

1.35

4.41

1.6

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

408

3059

1.25

4.41

1.6

1.4

0.28

0.38

nmol/l

3.23

307

2333

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.65

4.41

1.1

1.00

1.36

u/field

0.44

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

301

1.80

4.29

1.4

8.50

12.36

0.77

159

(3039443) Prostate specific Ag panel - Serum or Plasma

312

3685

0.79

4.27

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

441

1.65

4.26

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

594

1.55

4.24

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

514

1.60

4.23

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2476

21239

1.09

4.22

2.1

2.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

236

1.90

4.21

3.6

3.2

1.84

1.07

mg/l

0.71

167

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

135

2.21

4.20

1.4

17.98

18.21

pmol/l

0.03

113

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

261

3141

0.77

4.17

1.4

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

627

4944

1.18

4.09

5.2

3.3

25.37

26.67

mg/l

0.46

402

3138

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

272

1.82

4.08

2.2

3.3

34.52

41.01

umol/l

1.21

232

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

143

2.15

4.07

2.5

2.2

12.42

18.89

0.39

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

5.82

4.05

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

281

1.79

3.98

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.49

3.95

21.4

13.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

171

1161

1.37

3.90

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

326

3781

0.80

3.86

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

512

1.57

3.85

1.4

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.40

3.84

1.5

1.2

0.08

0.07

g/l

0.14

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.50

3.81

1.0

1.1

143.92

245.50

pmol/l

1.14

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

135

2.14

3.80

1.2

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

588

1.52

3.79

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

167

2.01

3.76

4.0

2.3

243.03

376.03

umol/l

0.64

159

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

130

2.15

3.73

1.1

—

(44813793) Dust mix specific IgE antibody measurement

232

1661

1.30

3.72

1.0

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

368

1.65

3.60

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

102

2.28

3.59

1.0

0.16

0.14

u/ml

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

198

1.88

3.49

1.3

1.2

101.90

108.36

ug/l

0.12

127

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

937

7723

1.13

3.43

2.0

1.8

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.85

3.43

1.1

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

154

2.00

3.42

3.6

4.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

185

1301

1.33

3.41

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

410

1.59

3.40

1.1

0.78

3.24

u/ml

0.80

339

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

597

1.48

3.37

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

181

1.90

3.36

1.1

9.20

17.44

iu/ml

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

9.31

3.34

1.0

—

(36303858) Crystals [Presence] in Urine

3.73

3.33

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

2.96

3.32

1.4

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

222

1.80

3.31

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

100

2.24

3.30

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

244

1.76

3.25

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.79

3.23

1.6

2.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

334

2546

1.22

3.22

2.3

2.1

11.88

7.39

umol/l

0.97

250

1869

(3019832) Treponema pallidum Ab [Presence] in Serum

2203

19043

1.08

3.20

1.7

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

6.52

3.19

2.7

1.5

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

4.66

3.16

1.4

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

317

1.65

3.15

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

554

1.48

3.12

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

600

1.46

3.12

1.1

—

(40768800) Prostate Pathology biopsy report

325

3676

0.82

3.11

1.2

—

(37019676) Renin [Units/volume] in Plasma --supine

2.61

3.06

1.1

11.59

77.57

mu/l

1.52

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

291

1.67

3.06

2.8

2.4

0.50

0.63

u/field

0.50

291

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1030

0.67

3.04

1.2

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.23

3.02

1.1

1.0

0.18

0.07

u/ml

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

243

1.73

3.02

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

314

1.63

3.01

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

607

4912

1.15

2.97

2.1

1.7

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

3.88

2.97

2.9

2.8

1.83

2.46

ug/l

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.29

2.94

2.5

5.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

199

1447

1.28

2.93

1.1

10.92

8.34

iu/ml

0.65

338

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1153

0.69

2.92

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2689

23514

1.07

2.89

2.2

2.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.22

2.88

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

132

1.98

2.87

1.1

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.19

2.85

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

370

1.56

2.85

1.4

1.6

—

(3020491) Glucose [Moles/volume] in Blood

227

1685

1.26

2.84

1.9

1.8

7.27

6.82

mmol/l

1.06

157

1214

(46236302) HLA-C [Type] by High resolution typing

2.36

2.83

1.0

—

(40760409) HLA-A [Type] by High resolution

2.36

2.83

1.0

—

(40760410) HLA-B [Type] by High resolution

2.36

2.83

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

545

1.45

2.79

10.4

8.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

153

1083

1.32

2.78

2.1

109.76

102.62

ug/min

0.05

239

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

447

1.50

2.78

1.2

0.94

41.44

mg/l

1.42

332

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.11

2.77

1.5

1.4

0.67

0.63

u/field

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.40

2.77

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

121

2.00

2.76

1.4

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

251

1.67

2.72

1.1

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

6.21

2.72

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

6.21

2.72

1.8

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

135

1.93

2.71

1.1

—

(3013862) HLA-DP [Type]

2.30

2.67

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

355

1.55

2.64

2.8

2.7

2227.50

1762.77

u/l

0.16

323

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

232

1.69

2.64

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

211

1.72

2.64

3.7

3.2

—

(3008896) Cortisol [Moles/volume] in Urine

7.76

2.62

1.4

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

157

1.84

2.60

1.3

22.03

21.73

mmol/l

0.10

115

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

299

1.59

2.56

1.3

42.08

53.32

1.01

149

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.59

2.55

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

518

1.44

2.53

1.4

1.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

293

1.59

2.52

2.9

2.6

60.52

76.47

pmol/l

0.57

252

(3013247) Albumin in CSF/Albumin in Serum or Plasma

473

1.46

2.51

1.1

6.76

7.05

mg/g

0.14

452

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

272

1.61

2.49

1.0

0.27

0.26

u/ml

0.01

172

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

180

1326

1.27

2.46

1.6

1.4

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

161

1.79

2.43

1.4

38.41

37.12

0.06

107

(40763590) HLA-DQ beta [Type]

2.23

2.39

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.23

2.39

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.35

2.38

1.1

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

278

1.58

2.31

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

130

1.86

2.30

4.2

3.6

5.67

13.25

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

507

1.42

2.27

1.1

24.48

0.78

umol/24h

0.49

246

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.12

2.26

1.2

1.4

451.27

517.41

nmol/l

0.18

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

172

1.73

2.26

2.8

2.7

168.54

60.17

pmol/l

0.28

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

750

7751

0.90

2.22

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.14

2.18

1.3

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

629

1.36

2.18

1.1

3.58

10.00

u/ml

0.54

334

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

153

1.77

2.18

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

306

1.52

2.14

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

577

1.37

2.12

1.2

1.3

30.94

337.58

ug/l

3.31

314

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

134

1.81

2.12

1.0

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

134

1.81

2.12

1.3

1.8

202.21

184.57

ug/g

0.16

115

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.29

2.10

1.0

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.29

2.10

2.2

1.2

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

101

1.94

2.10

1.1

8.58

8.61

0.01

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

101

1.94

2.10

1.1

21.56

21.18

0.12

(3038071) Oxygen [Partial pressure] in Mixed venous blood

476

1.41

2.10

11.4

8.2

—

(3010937) Rubella virus Ab [Presence] in Serum

108

1.90

2.08

1.2

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.89

2.04

1.2

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

646

1.34

2.02

1.1

1.0

7.05

11.66

u/ml

1.45

363

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

200

1.63

2.01

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

266

1.54

2.01

13.5

6.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

464

3807

1.14

1.99

1.1

5.80

5.31

u/ml

0.23

246

1938

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.21

1.96

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

981

0.74

1.93

2.1

1.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

181

1.65

1.92

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

517

4286

1.13

1.90

1.1

2.28

2.05

u/ml

0.19

288

2135

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

128

942

1.27

1.85

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.09

1.84

1.2

1.1

—

(3014891) Appearance of Pleural fluid

282

1.49

1.77

1.4

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

450

3722

1.13

1.75

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.24

1.73

1.4

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.96

1.73

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.93

1.72

1.1

6834.17

4001.37

ng/l

0.28

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

3.29

1.71

1.2

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

3.29

1.71

1.2

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

181

1.60

1.68

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

257

1.49

1.64

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

189

1475

1.19

1.62

1.0

305.00

341.03

ng/l

0.57

130

1038

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

190

1484

1.19

1.61

1.0

37.24

43.33

ng/l

1.34

127

1028

(3028468) Fragments [Presence] in Blood by Light microscopy

3.58

1.60

4.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.33

1.58

2.0

2.4

1.45

2.68

mu/l

—

(3027874) Urate [Moles/volume] in Urine

2.01

1.58

1.1

1.0

0.69

1.78

mmol/l

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.48

1.57

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.48

1.57

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.48

1.57

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.48

1.57

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.48

1.57

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.48

1.57

2.0

—

(3007147) Virus identified in Stool by Electron microscopy

3.33

1.50

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

647

5510

1.10

1.50

1.4

131.21

151.06

pmol/l

0.93

628

5369

(3012989) Citrate [Moles/time] in 24 hour Urine

2.47

1.48

1.3

1.6

1.92

2.07

mmol/24h

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

121

1383

0.81

1.48

1.2

1.3

1.58

1.56

g/l

0.29

121

1383

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

188

1483

1.18

1.46

1.0

763.03

733.27

ng/l

0.39

122

1008

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.79

1.46

1.0

1.1

—

(3032641) Amino acids panel - Urine

2.79

1.46

1.5

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

437

3657

1.11

1.45

1.1

1.08

1.20

u/ml

0.14

199

1566

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

219

1.49

1.44

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

109

1.71

1.43

1.2

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

127

0.44

1.40

1.2

1.1

7.40

8.47

mmol/l

—

127

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

124

1.65

1.40

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

180

1421

1.18

1.40

6.7

6.5

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

117

1.67

1.39

1.1

1.2

—

10925.00

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

146

1.60

1.39

1.0

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.66

1.38

1.2

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.05

1.33

5.4

5.6

—

(1002224) Polysomnography panel

922

9189

0.93

1.32

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

261

2131

1.14

1.32

4.9

4.8

83.44

113.20

u/ml

0.33

666

(3050794) Legionella sp Ab [Presence] in Serum

186

1.50

1.31

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

319

1.37

1.29

1.2

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

120

1.63

1.28

1.1

5.70

2.14

u/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

358

2989

1.12

1.27

1.1

3.69

4.40

u/ml

0.35

182

1417

(21494567) Legionella sp IgM Ab [Presence] in Serum

150

1.55

1.26

1.0

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.72

1.26

1.1

129.50

541.71

u/l

1.88

(3023430) Cat dander IgE Ab [Units/volume] in Serum

334

2780

1.12

1.26

1.0

1.1

4.39

5.00

u/ml

0.23

141

1141

(3051101) Glucose [Moles/volume] in Cord blood

406

0.69

1.25

4.6

5.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

417

3524

1.10

1.20

1.1

1.62

1.88

u/ml

0.23

221

1778

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1189

10472

1.06

1.18

2.0

1.8

—

(3007463) Buprenorphine [Presence] in Urine

1.75

1.18

6.9

6.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

102

1.64

1.15

1.0

1.1

0.08

0.49

u/ml

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

200

1.44

1.14

1.2

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

122

1349

0.84

1.12

1.4

1.6

7.74

7.91

mmol/l

0.38

115

1297

(3001556) Androgen free Index in Serum or Plasma

186

1.45

1.11

1.6

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

723

0.79

1.10

1.6

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

110

855

1.20

1.08

1.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

104

805

1.20

1.07

1.1

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.10

1.04

1.0

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1473

13110

1.05

1.02

2.1

1.9

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

350

1.30

1.01

2.0

1.5

0.28

0.21

nmol/l

0.33

253

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

458

1.26

1.00

2.5

1.6

2.25

3.01

ug/l

0.55

268

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.64

0.98

1.5

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

164

1331

1.15

0.98

1.1

0.43

2.28

u/ml

2.54

439

(3027974) Hepatitis B virus e Ag [Presence] in Serum

115

1.54

0.97

1.2

1.6

—

(3000285) Sodium [Moles/volume] in Blood

280

1.33

0.96

1.3

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

138

1.48

0.96

1.0

0.26

0.22

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

321

1.31

0.95

1.7

1.6

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.68

0.93

1.0

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

132

1.48

0.91

1.0

0.19

1.42

u/ml

0.72

103

(3032868) Hemoglobin electrophoresis panel in Blood

187

1.39

0.90

1.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

156

1273

1.14

0.89

10.8

12.0

0.63

0.62

mmol/l

0.22

146

1165

(3006567) Chloride [Moles/time] in 24 hour Urine

1.86

0.87

1.0

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.00

0.86

1.3

1.5

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.93

0.83

1.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

700

1.18

0.83

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

159

1.41

0.82

1.0

1.1

10.00

9.87

u/l

0.02

159

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

313

1.28

0.82

1.0

67.52

81.03

ug/l

1.94

246

(3003338) MCHC [Mass/volume]

21131

195655

1.02

0.81

30.8

17.4

331.03

332.29

g/l

71.63

20991

194068

(3022670) pH of Venous cord blood

1.86

0.81

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

668

1.19

0.80

1.7

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

282

2401

1.09

0.79

1.0

1.1

1.09

0.45

u/ml

0.79

655

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.66

0.78

2.1

2.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

2.12

0.75

1.0

1.1

66.74

70.11

—

(3000034) Microalbumin [Mass/volume] in Urine

247

2097

1.10

0.75

3.3

3.0

101.38

42.50

mg/l

1.35

183

1479

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

211

1.32

0.74

1.0

0.03

0.14

u/ml

1.87

126

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

139

1.41

0.74

1.1

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.63

0.72

1.0

1.1

—

mmol/l

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

1.76

0.71

2.1

8.24

19.29

ng/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

134

1.39

0.67

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

365

1.22

0.67

2.1

1.7

—

(3015183) Erythrocyte sedimentation rate

132

1092

1.13

0.67

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.59

0.65

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.72

0.63

3.0

2.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

368

1.21

0.63

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

193

1.30

0.62

2.3

2.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

384

3353

1.07

0.62

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

384

3357

1.07

0.60

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

269

1.25

0.60

1.3

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

142

1191

1.11

0.59

1.2

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.45

0.59

1.0

1.1

0.04

0.70

u/ml

—

(3018291) Platelet Ab [Presence] in Serum

1.75

0.58

1.3

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

179

1.30

0.58

1.0

0.13

0.48

u/ml

0.93

101

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.69

0.57

1.0

0.04

0.18

u/ml

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.46

0.56

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.47

0.54

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

439

0.83

0.54

2.6

3.2

—

(3020650) Glucose [Presence] in Urine

574

1.15

0.54

1.6

1.4

—

(3008607) Semen analysis panel

116

1.36

0.54

1.5

1.2

—

(40758358) Immune stain study

108

1.38

0.54

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

1.53

0.53

1.0

1.1

3.39

3.57

kpa

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

438

0.83

0.53

5.3

6.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

480

1.16

0.52

2.2

2.3

7.50

7.49

mmol/l

0.01

283

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.42

0.52

1.4

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.51

0.52

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

301

2632

1.07

0.50

1.5

—

(3009677) Dengue virus Ab [Presence] in Serum

1.43

0.49

1.3

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

227

1.23

0.48

1.1

22.14

19.63

u/l

0.32

149

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

119

1.33

0.47

1.0

0.02

0.32

u/ml

2.77

107

(3006598) pH of Arterial cord blood

1.48

0.47

1.0

1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

1.48

0.47

1.0

1.1

6.98

7.17

kpa

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.48

0.47

1.0

1.1

3.43

2.48

—

(40765089) Chromosome analysis panel - Blood by G-banded

565

1.14

0.46

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.38

0.42

1.1

206.25

280.15

nmol/l

1.07

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

527

1.13

0.41

2.9

2.8

143.80

118.66

ng/l

0.36

244

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.33

0.40

1.1

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.38

0.39

1.1

1.0

—

(3013762) Body weight Measured

1.38

0.39

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

115

1.30

0.39

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

115

1.30

0.39

1.3

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

268

1.18

0.38

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

216

1892

1.06

0.38

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

281

0.83

0.38

1.8

2.4

—

(3029612) Listeria sp Ab [Titer] in Serum

1.37

0.37

1.2

1.3

—

(3025130) Human papilloma virus identified in Specimen

339

3018

1.05

0.35

1.8

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

632

1.11

0.35

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

645

6200

0.97

0.35

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

151

1.23

0.35

1.1

71.04

30.44

u/ml

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

211

1.19

0.34

1.1

1.0

0.29

1.45

u/ml

1.46

160

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

289

1.16

0.34

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

495

0.88

0.34

2.6

2.8

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

212

1.19

0.33

1.1

1.0

0.03

2.24

u/ml

2.36

156

(3016031) Almond IgE Ab [Units/volume] in Serum

127

1.25

0.32

1.1

1.0

0.29

0.69

u/ml

1.17

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

218

1925

1.05

0.32

1.2

1.3

9.53

8.52

mmol/l

2.32

207

1842

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.36

0.31

1.0

—

1.30

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.72

0.31

1.1

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

773

0.92

0.30

2.1

2.4

147.89

150.06

nmol/l

0.07

668

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2265

20792

1.02

0.29

1.4

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

198

1.18

0.29

1.0

0.57

2.58

u/ml

0.53

105

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.23

0.29

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

147

1.20

0.28

1.1

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3980

37431

0.99

0.28

1.5

1.4

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.24

0.27

1.0

77.38

425.76

u/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

775

7048

1.02

0.27

1.5

—

(3022475) Manganese [Moles/volume] in Blood

139

1.21

0.27

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

150

0.81

0.27

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

121

1197

0.94

0.25

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

312

3013

0.96

0.25

1.3

7.12

7.28

mmol/l

0.49

279

2649

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

245

1.14

0.25

1.1

13.79

1.73

umol/24h

0.49

245

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

263

1.13

0.24

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

158

1.18

0.24

1.1

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

845

8034

0.98

0.24

1.9

1.7

5.16

3.68

mg/l

2.47

665

5843

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

193

1.16

0.24

1.0

1.68

1.01

u/ml

0.15

108

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

162

1438

1.05

0.23

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

320

1.11

0.21

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.27

0.20

1.2

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6522

61063

0.99

0.19

5.1

4.7

3.64

3.15

ug/l

0.25

5771

54995

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

252

0.89

0.19

1.1

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.14

0.19

1.8

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

914

0.95

0.18

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

147

1314

1.04

0.17

1.0

0.49

4.35

u/ml

1.03

332

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.74

0.17

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

112

0.83

0.17

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.18

0.16

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

179

1610

1.04

0.16

1.4

1.3

155.99

177.15

pmol/l

1.35

179

1610

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

138

1.15

0.16

1.1

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

264

2391

1.03

0.16

1.5

1.4

3.33

3.99

ug/l

0.57

226

2057

(3015076) Soybean IgE Ab [Units/volume] in Serum

120

1163

0.96

0.15

1.1

1.0

3.34

0.80

u/ml

0.40

296

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

198

0.89

0.14

6.9

7.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

126

1216

0.96

0.13

1.3

5.74

5.75

mmol/l

0.04

119

1145

(4281824) Cell count and differential, peritoneal fluid

292

2660

1.02

0.13

1.2

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

889

0.96

0.11

1.3

1.4

27.87

30.64

nmol/l

0.42

799

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

363

1.05

0.08

1.1

2.86

6.32

u/ml

0.72

259

(46235168) Fasting glucose [Moles/volume] in Blood

268

0.94

0.08

1.7

2.2

7.44

7.49

mmol/l

—

109

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

115

0.89

0.08

1.2

1.0

8.06

19.77

u/ml

1.06

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

163

1.09

0.08

1.1

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

172

0.92

0.08

1.1

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.02

0.07

2.1

1.0

854.43

355.19

pmol/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

104

0.90

0.07

8.2

8.9

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

113

0.91

0.06

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

258

1.05

0.05

1.3

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

123

1.06

0.02

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

222

0.96

0.02

2.3

2.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

264

2445

1.01

0.02

1.2

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

369

0.98

0.00

5.9

7.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

196

1.00

0.00

1.0

1.1

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.0

5.7

—

139.57

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.99

0.00

1.2

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.0

1.1

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

0.97

0.00

3.0

1.4

0.20

0.52

—

(3025311) HLA-B [Type]

0.00

-0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.5

—

4.00

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_OSTEOCHONDRO and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_OSTEOCHONDRO	1.802 [1.64, 1.98]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.049

During the follow-up period (1.1.1998 — 31.12.2019), 36202 out of 109937 females with M13_OSTEOCHONDRO died.

Males

Parameter	HR [95% CI]	p-value
M13_OSTEOCHONDRO	2.271 [2.03, 2.54]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 13676 out of 59070 males with M13_OSTEOCHONDRO died.

Mortality risk

Mortality risk for people of age

years, who have M13_OSTEOCHONDRO.

N-year risk	Females	Males
1	0.185%	0.472%
5	1.041%	2.637%
10	2.385%	6.006%
15	4.319%	11.435%
20	7.194%	19.301%

Relationships between endpoints

↥

Index endpoint: M13_OSTEOCHONDRO – Osteopathies and chondropathies

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Osteopathies and chondropathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints